CN113683517A - Aromatic amine derivative organic electroluminescent material and device thereof - Google Patents

Aromatic amine derivative organic electroluminescent material and device thereof Download PDF

Info

Publication number
CN113683517A
CN113683517A CN202010418297.9A CN202010418297A CN113683517A CN 113683517 A CN113683517 A CN 113683517A CN 202010418297 A CN202010418297 A CN 202010418297A CN 113683517 A CN113683517 A CN 113683517A
Authority
CN
China
Prior art keywords
substituted
carbon atoms
unsubstituted
group
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010418297.9A
Other languages
Chinese (zh)
Inventor
田学超
毕欣
张少博
王峥
赵春亮
邝志远
夏传军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Summer Sprout Technology Co Ltd
Original Assignee
Beijing Summer Sprout Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Summer Sprout Technology Co Ltd filed Critical Beijing Summer Sprout Technology Co Ltd
Priority to CN202010418297.9A priority Critical patent/CN113683517A/en
Publication of CN113683517A publication Critical patent/CN113683517A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/57Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems of the carbon skeleton
    • C07C211/61Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems of the carbon skeleton with at least one of the condensed ring systems formed by three or more rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/72Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • H10K85/622Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing four rings, e.g. pyrene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • H10K85/626Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing more than one polycyclic condensed aromatic rings, e.g. bis-anthracene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/631Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/631Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
    • H10K85/633Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine comprising polycyclic condensed aromatic hydrocarbons as substituents on the nitrogen atom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/631Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
    • H10K85/636Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine comprising heteroaromatic hydrocarbons as substituents on the nitrogen atom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6574Polycyclic condensed heteroaromatic hydrocarbons comprising only oxygen in the heteroaromatic polycondensed ring system, e.g. cumarine dyes
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6576Polycyclic condensed heteroaromatic hydrocarbons comprising only sulfur in the heteroaromatic polycondensed ring system, e.g. benzothiophene
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1007Non-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1011Condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1014Carbocyclic compounds bridged by heteroatoms, e.g. N, P, Si or B
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1088Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1092Heterocyclic compounds characterised by ligands containing sulfur as the only heteroatom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Optics & Photonics (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

Disclosed are an aromatic amine derivative organic electroluminescent material and a device thereof. The compound is an aromatic amine substituted pyrene compound, wherein the compound has a substituted or unsubstituted (hetero) aryl and penta (hetero) cyclic hydrocarbon and a substituted or unsubstituted bi (hetero) aryl aromatic amine structure, and can be used as a light-emitting material in an organic electroluminescent device. These novel compounds can provide better device performance such as higher external quantum efficiency and narrower half-peak width.

Description

Aromatic amine derivative organic electroluminescent material and device thereof
Technical Field
The present invention relates to compounds for use in organic electronic devices, such as organic light emitting devices. And more particularly, to a pyrene compound substituted with an aromatic amine and an organic electroluminescent device and a compound formulation including the same.
Background
Organic electronic devices include, but are not limited to, the following classes: organic Light Emitting Diodes (OLEDs), organic field effect transistors (O-FETs), Organic Light Emitting Transistors (OLETs), Organic Photovoltaics (OPVs), dye-sensitized solar cells (DSSCs), organic optical detectors, organic photoreceptors, organic field effect devices (OFQDs), light emitting electrochemical cells (LECs), organic laser diodes, and organic plasma light emitting devices.
In 1987, Tang and Van Slyke of Islamic Kodak reported a two-layer organic electroluminescent device comprising an arylamine hole transport layer and a tris-8-hydroxyquinoline-aluminum layer as an electron transport layer and a light-emitting layer (Applied Physics Letters, 1987,51(12): 913-915). Upon biasing the device, green light is emitted from the device. The invention lays a foundation for the development of modern Organic Light Emitting Diodes (OLEDs). The most advanced OLEDs may comprise multiple layers, such as charge injection and transport layers, charge and exciton blocking layers, and one or more light emitting layers between the cathode and anode. Since OLEDs are a self-emissive solid state device, it offers great potential for display and lighting applications. Furthermore, the inherent properties of organic materials, such as their flexibility, may make them well suited for particular applications, such as in the fabrication of flexible substrates.
OLEDs can be classified into three different types according to their light emitting mechanisms. The OLEDs invented by Tang and van Slyke are fluorescent OLEDs. It uses only singlet luminescence. The triplet states generated in the device are wasted through the non-radiative decay channel. Therefore, the Internal Quantum Efficiency (IQE) of fluorescent OLEDs is only 25%. This limitation hinders the commercialization of OLEDs. In 1997, Forrest and Thompson reported phosphorescent OLEDs, which use triplet emission from complex-containing heavy metals as emitters. Thus, singlet and triplet states can be harvested, achieving 100% IQE. Due to its high efficiency, the discovery and development of phosphorescent OLEDs directly contributes to the commercialization of active matrix OLEDs (amoleds). Recently, Adachi has achieved high efficiency through Thermally Activated Delayed Fluorescence (TADF) of organic compounds. These emitters have a small singlet-triplet gap, making it possible for excitons to return from the triplet state to the singlet state. In TADF devices, triplet excitons are able to generate singlet excitons through reverse intersystem crossing, resulting in high IQE.
The light emitting color of the OLED can be realized by the structural design of the light emitting material. An OLED may comprise one light emitting layer or a plurality of light emitting layers to achieve a desired spectrum. Green, yellow and red OLED phosphorescent materials have been successfully commercialized. The existing phosphorescent blue OLED has the problems of short service life, difficulty in reaching deep blue, blue unsaturation, high working voltage and the like. The fluorescent blue OLED has a longer lifetime than the phosphorescent blue OLED, but has a low efficiency, and thus it is highly desirable to improve the efficiency and other properties of the fluorescent blue electroluminescent device.
WO2009107596A1 discloses triarylamine substituted pyrene compounds with benzo aliphatic ring, and the general formula of the compounds is
Figure BDA0002495366720000011
Wherein the substituent R21-R24Can be formed into a ring structure
Figure BDA0002495366720000012
Specifically, the following structure
Figure BDA0002495366720000021
The specific structure is disclosed as
Figure BDA0002495366720000022
And
Figure BDA0002495366720000023
however, the aromatic amines are not recognized in this patent applicationThe effect of introducing benzocyclohydrocarbons on device performance is also not disclosed and taught as having benzocyclohydrocarbon and biaryl structures that would enhance device performance.
CN107556239A discloses a pyrene compound containing an acridine structure, which has a general formula shown in the specification
Figure BDA0002495366720000024
Wherein Ar is1And Ar2Can be heterocyclic radical, and has specific structure
Figure BDA0002495366720000025
However, the application is mainly directed to a series of pyrene compounds with acridine substituted aromatic amine, and does not pay attention to improvement of device performance caused by benzo-heterocyclic hydrocarbon, and does not disclose and teach device effects obtained by introducing benzo-cyclic hydrocarbon or benzo-heterocyclic hydrocarbon into aromatic amine and using another aryl group in the aromatic amine as biaryl.
These documents disclose fluorescent light-emitting materials having an aromatic amine structure with pyrene as a core. However, the fluorescent light-emitting material still needs to be developed further to obtain higher device performance.
Disclosure of Invention
The present invention aims to solve at least part of the above problems by providing a novel series of pyrene-based compounds having an aromatic amine structure of a substituted or unsubstituted (hetero) aryl-fused five-membered (hetero) cyclic hydrocarbon and a substituted or unsubstituted di (hetero) aryl group.
According to one embodiment of the present invention, a compound having the structure of formula 1 is disclosed:
Figure BDA0002495366720000031
wherein, in the formula 1,
substituent R1-R10At least one of which has the structure of formula 2:
Figure BDA0002495366720000032
and the substituent R1-R10The remaining of (a) are, identically or differently on each occurrence, selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amino, acyl, carbonyl, carboxylic acid group, ester group, cyano, isocyano, mercapto, sulfinyl, sulfonyl, phosphino, and combinations thereof, having from 0 to 20 carbon atoms;
wherein, in the formula 2,
l is selected from a single bond, a substituted or unsubstituted arylene group having 6 to 60 carbon atoms, a substituted or unsubstituted heteroarylene group having 3 to 60 carbon atoms, or a combination thereof;
X1-X3selected from CR, identically or differently at each occurrencexOr N;
Y1and Y5Selected from CR, identically or differently at each occurrencey1Or N;
Y2-Y4selected from CR, identically or differently at each occurrencey2、CRy3Or N, and Y2-Y4At least one of which is CRy2
Z is selected from C (R), identically or differently on each occurrencez)2,NRzO, S or Se;
Rx、Ry3and RzEach occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted having 1 to 20 carbon atomsA substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, a substituted or unsubstituted heteroalkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted aralkyl group having 7 to 30 carbon atoms, a substituted or unsubstituted alkoxy group having 1 to 20 carbon atoms, a substituted or unsubstituted aryloxy group having 6 to 30 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 20 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, a substituted or unsubstituted amino group having 0 to 20 carbon atoms, acyl, carbonyl, carboxylic acid group, ester group, cyano, isocyano, mercapto, sulfinyl, sulfonyl, phosphino, and combinations thereof;
Ry1each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, and combinations thereof;
Ry2each occurrence, identically or differently, is selected from a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, or a combination thereof;
adjacent substituents Rx、Ry1、Ry3Can optionally be linked to form a ring;
substituent RzCan optionally be linked to form a ring;
and represents the position of the substituent with the structure of the formula 2 connected with the formula 1.
According to another embodiment of the present invention, there is also disclosed an electroluminescent device comprising the compound having the structure of formula 1. The specific structures of the compounds are described in the preceding examples.
According to another embodiment of the present invention, there is also disclosed a compound formulation comprising the compound having the structure of formula 1. Specific structures of the compounds are described in the preceding examples.
The invention provides a series of novel pyrene compounds with substituted or unsubstituted (hetero) aryl five-membered (hetero) cyclic hydrocarbon and substituted or unsubstituted bi (hetero) aryl aromatic amine structures, which can be used as luminescent materials in organic electroluminescent devices. These novel compounds can provide better device performance such as higher external quantum efficiency and narrower half-peak width.
Drawings
FIG. 1 is a schematic representation of an organic light emitting device that can contain the compounds and compound formulations disclosed herein.
Fig. 2 is a schematic view of another organic light emitting device that can contain compounds and compound formulations disclosed herein.
Detailed Description
OLEDs can be fabricated on a variety of substrates, such as glass, plastic, and metal. Fig. 1 schematically, but without limitation, illustrates an organic light emitting device 100. The figures are not necessarily to scale, and some of the layer structures in the figures may be omitted as desired. The device 100 may include a substrate 101, an anode 110, a hole injection layer 120, a hole transport layer 130, an electron blocking layer 140, an emissive layer 150, a hole blocking layer 160, an electron transport layer 170, an electron injection layer 180, and a cathode 190. The device 100 may be fabricated by sequentially depositing the described layers. The nature and function of the layers, as well as exemplary materials, are described in more detail in U.S. patent US7,279,704B2, columns 6-10, which is incorporated herein by reference in its entirety.
There are more instances of each of these layers. For example, a flexible and transparent substrate-anode combination is disclosed in U.S. Pat. No. 5,844,363, which is incorporated by reference in its entirety. An example of a p-doped hole transport layer is doped with F at a molar ratio of 50:14TCNQ m-MTDATA as disclosed in U.S. patent application publication No. 2003/0230980, which is incorporated by reference in its entirety. Examples of host materials are disclosed in U.S. patent No. 6,303,238 to Thompson et al, which is incorporated by reference in its entirety. An example of an n-doped electron transport layer is BPhen doped with Li at a molar ratio of 1:1, as in U.S. patent application publication No. 2003 @, which is incorporated by reference in its entirety0230980 to Kokai. U.S. Pat. Nos. 5,703,436 and 5,707,745, which are incorporated by reference in their entirety, disclose examples of cathodes including composite cathodes having a thin layer of a metal such as Mg: Ag and an overlying layer of transparent, conductive, sputter-deposited ITO. The principles and use of barrier layers are described in more detail in U.S. patent No. 6,097,147 and U.S. patent application publication No. 2003/0230980, which are incorporated by reference in their entirety. Examples of injection layers are provided in U.S. patent application publication No. 2004/0174116, which is incorporated by reference in its entirety. A description of the protective layer may be found in U.S. patent application publication No. 2004/0174116, which is incorporated by reference in its entirety.
The above-described hierarchical structure is provided via non-limiting embodiments. The function of the OLED may be achieved by combining the various layers described above, or some layers may be omitted entirely. It may also include other layers not explicitly described. Within each layer, a single material or a mixture of materials may be used to achieve optimal performance. Any functional layer may comprise several sub-layers. For example, the light emitting layer may have two layers of different light emitting materials to achieve a desired light emission spectrum.
In one embodiment, an OLED may be described as having an "organic layer" disposed between a cathode and an anode. The organic layer may include one or more layers.
The OLED also requires an encapsulation layer, as shown in fig. 2, which is an exemplary, non-limiting illustration of an organic light emitting device 200, which differs from fig. 1 in that an encapsulation layer 102 may also be included over the cathode 190 to protect against harmful substances from the environment, such as moisture and oxygen. Any material capable of providing an encapsulation function may be used as the encapsulation layer, such as glass or a hybrid organic-inorganic layer. The encapsulation layer should be placed directly or indirectly outside the OLED device. Multilayer film encapsulation is described in U.S. patent US7,968,146B2, the entire contents of which are incorporated herein by reference.
Devices manufactured according to embodiments of the present invention may be incorporated into various consumer products having one or more electronic component modules (or units) of the device. Some examples of such consumer products include flat panel displays, monitors, medical monitors, televisions, billboards, lights for indoor or outdoor lighting and/or signaling, head-up displays, fully or partially transparent displays, flexible displays, smart phones, tablet computers, tablet handsets, wearable devices, smart watches, laptop computers, digital cameras, camcorders, viewfinders, micro-displays, 3-D displays, vehicle displays, and tail lights.
The materials and structures described herein may also be used in other organic electronic devices as previously listed.
As used herein, "top" means furthest from the substrate, and "bottom" means closest to the substrate. Where a first layer is described as being "disposed on" a second layer, the first layer is disposed farther from the substrate. Other layers may be present between the first and second layers, unless it is specified that the first layer is "in contact with" the second layer. For example, a cathode can be described as being "disposed on" an anode even though various organic layers are present between the cathode and the anode.
As used herein, "solution processable" means capable of being dissolved, dispersed or transported in and/or deposited from a liquid medium in the form of a solution or suspension.
A ligand may be referred to as "photoactive" when it is believed that the ligand directly contributes to the photoactive properties of the emissive material. A ligand may be referred to as "ancillary" when it is believed that the ligand does not contribute to the photoactive properties of the emissive material, but the ancillary ligand may alter the properties of the photoactive ligand.
It is believed that the Internal Quantum Efficiency (IQE) of fluorescent OLEDs can be limited by delaying fluorescence beyond 25% spin statistics. Delayed fluorescence can generally be divided into two types, i.e., P-type delayed fluorescence and E-type delayed fluorescence. P-type delayed fluorescence results from triplet-triplet annihilation (TTA).
On the other hand, E-type delayed fluorescence does not depend on collision of two triplet states, but on conversion between triplet and singlet excited states. Compounds capable of producing E-type delayed fluorescence need to have a very small mono-triplet gap in order to switch between energy states. Thermal energy can activate a transition from a triplet state back to a singlet state. This type of delayed fluorescence is also known as Thermally Activated Delayed Fluorescence (TADF). A significant feature of TADF is that the retardation component increases with increasing temperature. If the reverse intersystem crossing (IRISC) rate is fast enough to minimize non-radiative decay from the triplet state, then the fraction of the backfill singlet excited state may reach 75%. The total singlet fraction may be 100%, far exceeding 25% of the spin statistics of the electrogenerated excitons.
The delayed fluorescence characteristic of type E can be found in excited complex systems or in single compounds. Without being bound by theory, it is believed that E-type delayed fluorescence requires the light emitting material to have a small mono-triplet energy gap (Δ Ε)S-T). Organic non-metal containing donor-acceptor emissive materials may be able to achieve this. The emission of these materials is generally characterized as donor-acceptor Charge Transfer (CT) type emission. Spatial separation of HOMO from LUMO in these donor-acceptor type compounds generally results in small Δ ES-T. These states may include CT states. Generally, donor-acceptor light emitting materials are constructed by linking an electron donor moiety (e.g., an amino or carbazole derivative) to an electron acceptor moiety (e.g., a six-membered, N-containing, aromatic ring).
Definitions for substituent terms
Halogen or halide-as used herein, includes fluorine, chlorine, bromine and iodine.
Alkyl-comprises both straight and branched chain alkyl groups. Examples of alkyl groups include methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, n-tridecyl, n-tetradecyl, n-pentadecyl, n-hexadecyl, n-heptadecyl, n-octadecyl, neopentyl, 1-methylpentyl, 2-methylpentyl, 1-pentylhexyl, 1-butylpentyl, 1-heptyloctyl, 3-methylpentyl. In addition, the alkyl group may be optionally substituted. The carbons in the alkyl chain may be substituted with other heteroatoms. Among the above, methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl and neopentyl are preferable.
Cycloalkyl-as used herein, comprises a cyclic alkyl group. Preferred cycloalkyl groups are those containing 4 to 10 ring carbon atoms and include cyclobutyl, cyclopentyl, cyclohexyl, 4-methylcyclohexyl, 4, 4-dimethylcyclohexyl, 1-adamantyl, 2-adamantyl, 1-norbornyl, 2-norbornyl and the like. In addition, the cycloalkyl group may be optionally substituted. The carbon in the ring may be substituted with other heteroatoms.
Alkenyl-as used herein, encompasses both straight and branched chain olefinic groups. Preferred alkenyl groups are those containing 2 to 15 carbon atoms. Examples of the alkenyl group include a vinyl group, an allyl group, a 1-butenyl group, a 2-butenyl group, a 3-butenyl group, a1, 3-butadienyl group, a 1-methylvinyl group, a styryl group, a 2, 2-diphenylvinyl group, a 1-methylallyl group, a1, 1-dimethylallyl group, a 2-methylallyl group, a 1-phenylallyl group, a 3, 3-diphenylallyl group, a1, 2-dimethylallyl group, a 1-phenyl-1-butenyl group and a 3-phenyl-1-butenyl group. In addition, alkenyl groups may be optionally substituted.
Alkynyl-as used herein, straight and branched alkynyl groups are contemplated. Preferred alkynyl groups are those containing 2 to 15 carbon atoms. In addition, alkynyl groups may be optionally substituted.
Aryl or aromatic-as used herein, non-fused and fused systems are contemplated. Preferred aryl groups are those containing from 6 to 60 carbon atoms, more preferably from 6 to 20 carbon atoms, and even more preferably from 6 to 12 carbon atoms. Examples of aryl groups include phenyl, biphenyl, terphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chicory, perylene and azulene, preferably phenyl, biphenyl, terphenyl, triphenylene, fluorene and naphthalene. In addition, the aryl group may be optionally substituted. Examples of non-fused aryl groups include phenyl, biphenyl-2-yl, biphenyl-3-yl, biphenyl-4-yl, p-terphenyl-4-yl, p-terphenyl-3-yl, p-triphenyl-2-yl, m-terphenyl-4-yl, m-terphenyl-3-yl, m-terphenyl-2-yl, o-tolyl, m-tolyl, p-tolyl, p- (2-phenylpropyl) phenyl, 4 '-methyldiphenyl, 4' -tert-butyl-p-terphenyl-4-yl, o-cumyl, m-cumyl, p-cumyl, 2, 3-xylyl, 3, 4-xylyl, 2, 5-xylyl, mesityl and m-quaterphenyl.
Heterocyclyl or heterocyclic-as used herein, aromatic and non-aromatic cyclic groups are contemplated. Heteroaryl also refers to heteroaryl. Preferred non-aromatic heterocyclic groups are those containing 3 to 7 ring atoms, which include at least one heteroatom such as nitrogen, oxygen and sulfur. The heterocyclic group may also be an aromatic heterocyclic group having at least one hetero atom selected from a nitrogen atom, an oxygen atom, a sulfur atom and a selenium atom.
Heteroaryl-as used herein, non-fused and fused heteroaromatic groups are contemplated which may contain 1 to 5 heteroatoms. Preferred heteroaryl groups are those containing from 3 to 30 carbon atoms, more preferably from 3 to 20 carbon atoms, more preferably from 3 to 12 carbon atoms. Suitable heteroaryl groups include dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridine indole, pyrrolopyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, bisoxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indoline, benzimidazole, indazole, indenozine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, benzothienopyridine, thienobipyridine, benzothiophenopyridine, cinnolinopyrimidine, selenobenzodipyridine, selenobenzene, preferably dibenzothiophene, dibenzofuran, dibenzoselenophene, carbazole, indolocarbazole, imidazole, pyridine, triazine, benzimidazole, 1, 2-azaborine, 1, 3-azaborine, 1, 4-azaborine, borazole, and aza analogues thereof. In addition, the heteroaryl group may be optionally substituted.
Alkoxy-is represented by-O-alkyl. Examples and preferred examples of the alkyl group are the same as those described above. Examples of the alkoxy group having 1 to 20 carbon atoms, preferably 1 to 6 carbon atoms include methoxy, ethoxy, propoxy, butoxy, pentyloxy and hexyloxy. The alkoxy group having 3 or more carbon atoms may be linear, cyclic or branched.
Aryloxy-is represented by-O-aryl or-O-heteroaryl. Examples and preferred examples of aryl and heteroaryl groups are the same as described above. Examples of the aryloxy group having 6 to 40 carbon atoms include a phenoxy group and a biphenyloxy group.
Aralkyl-as used herein, an alkyl group having an aryl substituent. In addition, the aralkyl group may be optionally substituted. Examples of the aralkyl group include benzyl, 1-phenylethyl, 2-phenylethyl, 1-phenylisopropyl, 2-phenylisopropyl, phenyl tert-butyl, α -naphthylmethyl, 1- α -naphthylethyl, 2- α -naphthylethyl, 1- α -naphthylisopropyl, 2- α -naphthylisopropyl, β -naphthylmethyl, 1- β -naphthylethyl, 2- β -naphthylethyl, 1- β -naphthylisopropyl, 2- β -naphthylisopropyl, p-methylbenzyl, m-methylbenzyl, o-methylbenzyl, p-chlorobenzyl, m-chlorobenzyl, o-chlorobenzyl, p-bromobenzyl, m-bromobenzyl, o-bromobenzyl, p-iodobenzyl, m-iodobenzyl, o-iodobenzyl, p-hydroxybenzyl, m-hydroxybenzyl, o-hydroxybenzyl, p-aminobenzyl, m-aminobenzyl, o-aminobenzyl, p-nitrobenzyl, m-nitrobenzyl, o-nitrobenzyl, p-cyanobenzyl, m-cyanobenzyl, o-cyanobenzyl, 1-2-hydroxy-2-phenylisopropyl and 1-chloro-2-phenylisopropyl. Among the above, benzyl, p-cyanobenzyl, m-cyanobenzyl, o-cyanobenzyl, 1-phenylethyl, 2-phenylethyl, 1-phenylisopropyl and 2-phenylisopropyl are preferable.
The term "aza" in azafluorene, azaspirobifluorene ring, azadibenzofuran, aza-dibenzothiophene, etc., means that one or more C-H groups in the corresponding aromatic moiety are replaced by a nitrogen atom. For example, azatriphenylenes include dibenzo [ f, h ] quinoxalines, dibenzo [ f, h ] quinolines, and other analogs having two or more nitrogens in the ring system. Other nitrogen analogs of the above-described aza derivatives may be readily envisioned by one of ordinary skill in the art, and all such analogs are intended to be encompassed within the terms described herein.
In this disclosure, unless otherwise defined, when any one of the terms in the group consisting of: substituted alkyl, substituted cycloalkyl, substituted heteroalkyl, substituted aralkyl, substituted alkoxy, substituted aryloxy, substituted alkenyl, substituted aryl, substituted heteroaryl, substituted alkylsilyl, substituted arylsilyl, substituted amino, substituted acyl, substituted carbonyl, substituted carboxylic acid, substituted ester, substituted sulfinyl, substituted sulfonyl, substituted phosphino, meaning alkyl, cycloalkyl, heteroalkyl, aralkyl, alkoxy, aryloxy, alkenyl, aryl, heteroaryl, alkylsilyl, arylsilyl, amino, acyl, carbonyl, carboxylic acid, ester, sulfinyl, sulfonyl and phosphino, any of which groups may be substituted with one or more members selected from deuterium, unsubstituted alkyl having 1 to 20 carbon atoms, unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, an unsubstituted heteroalkyl group having from 1 to 20 carbon atoms, an unsubstituted aralkyl group having from 7 to 30 carbon atoms, an unsubstituted alkoxy group having from 1 to 20 carbon atoms, an unsubstituted aryloxy group having from 6 to 30 carbon atoms, an unsubstituted alkenyl group having from 2 to 20 carbon atoms, an unsubstituted aryl group having from 6 to 30 carbon atoms or, preferably, an unsubstituted aryl group having from 6 to 12 carbon atoms, an unsubstituted heteroaryl group having from 3 to 30 carbon atoms or, preferably, an unsubstituted heteroaryl group having from 3 to 12 carbon atoms, an unsubstituted alkylsilyl group having from 3 to 20 carbon atoms, an unsubstituted arylsilyl group having from 6 to 20 carbon atoms, an unsubstituted amino group having from 0 to 20 carbon atoms, an acyl group, a carbonyl group, a carboxylic acid group, ester, cyano, isocyano, mercapto, sulfinyl, sulfonyl, phosphino, and combinations thereof.
It will be understood that when a molecular fragment is described as a substituent or otherwise attached to another moiety, its name may be written depending on whether it is a fragment (e.g., phenyl, phenylene, naphthyl, dibenzofuranyl) or depending on whether it is an entire molecule (e.g., benzene, naphthalene, dibenzofuran). As used herein, these different ways of specifying substituents or linking fragments are considered to be equivalent.
In the compounds mentioned in the present disclosure, a hydrogen atom may be partially or completely replaced by deuterium. Other atoms such as carbon and nitrogen may also be replaced by their other stable isotopes. Substitution of other stable isotopes in the compounds may be preferred because it enhances the efficiency and stability of the device. In the compounds mentioned in the present disclosure, a deuterated substituent, such as deuterated methyl, means that at least one hydrogen atom in said substituent (methyl) is replaced by deuterium.
In the compounds mentioned in the present disclosure, multiple substitution means that a double substitution is included up to the range of the maximum available substitutions. When a substituent in a compound mentioned in the present disclosure represents multiple substitution (including di-substitution, tri-substitution, tetra-substitution, etc.), that is, it means that the substituent may exist at a plurality of available substitution positions on its connecting structure, and the substituent existing at each of the plurality of available substitution positions may be the same structure or different structures.
In the compounds mentioned in the present disclosure, adjacent substituents in the compounds cannot be linked to form a ring unless specifically defined, for example, adjacent substituents can be optionally linked to form a ring. In the compounds mentioned in the present disclosure, adjacent substituents can be optionally linked to form a ring, including both the case where adjacent substituents may be linked to form a ring and the case where adjacent substituents are not linked to form a ring. When adjacent substituents can optionally be joined to form a ring, the ring formed can be monocyclic or polycyclic, as well as alicyclic, heteroalicyclic, aromatic or heteroaromatic rings. In this expression, adjacent substituents may refer to substituents bonded to the same atom, substituents bonded to carbon atoms directly bonded to each other, or substituents bonded to carbon atoms further away. Preferably, adjacent substituents refer to substituents bonded to the same carbon atom as well as substituents bonded to carbon atoms directly bonded to each other.
The expression that two adjacent substituents can optionally be linked to form a ring is also intended to mean that two substituents bonded to the same carbon atom are linked to each other by a chemical bond to form a ring, which can be exemplified by the following formula:
Figure BDA0002495366720000071
the expression that two adjacent substituents can optionally be linked to form a ring is also intended to mean that two substituents bonded to carbon atoms directly bonded to each other are linked to each other by a chemical bond to form a ring, which can be exemplified by the following formula:
Figure BDA0002495366720000072
further, the expression that two adjacent substituents can be optionally connected to form a ring is also intended to be taken to mean that, in the case where one of the two substituents bonded to the carbon atom directly bonded to each other represents hydrogen, the second substituent is bonded at the position to which the hydrogen atom is bonded, thereby forming a ring. This is exemplified by the following equation:
Figure BDA0002495366720000081
according to one embodiment of the present invention, a compound having the structure of formula 1 is disclosed:
Figure BDA0002495366720000082
wherein, in the formula 1,
substituent R1-R10At least one of which has the structure of formula 2:
Figure BDA0002495366720000083
and the substituent R1-R10The remaining of (a) are, identically or differently on each occurrence, selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy having 6 to 30 carbon atoms, substituted or unsubstitutedSubstituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amino groups having 0 to 20 carbon atoms, acyl groups, carbonyl groups, carboxylic acid groups, ester groups, cyano groups, isocyano groups, mercapto groups, sulfinyl groups, sulfonyl groups, phosphino groups, and combinations thereof;
wherein, in the formula 2,
l is selected from a single bond, a substituted or unsubstituted arylene group having 6 to 60 carbon atoms, a substituted or unsubstituted heteroarylene group having 3 to 60 carbon atoms, or a combination thereof;
X1-X3selected from CR, identically or differently at each occurrencexOr N;
Y1and Y5Selected from CR, identically or differently at each occurrencey1Or N;
Y2-Y4selected from CR, identically or differently at each occurrencey2、CRy3Or N, and Y2-Y4At least one of which is CRy2
Z is selected, identically or differently on each occurrence, from C (R)z)2,NRzO, S or Se;
Rx、Ry3and RzEach occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl having 2 to 20 carbon atoms, substituted or unsubstituted aryl having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl having 3 to 20 carbon atoms, substituted or unsubstitutedAn arylsilyl group having 6 to 20 carbon atoms, a substituted or unsubstituted amino group having 0 to 20 carbon atoms, an acyl group, a carbonyl group, a carboxylic acid group, an ester group, a cyano group, an isocyano group, a mercapto group, a sulfinyl group, a sulfonyl group, a phosphino group, and combinations thereof;
Ry1each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, and combinations thereof;
Ry2each occurrence, identically or differently, is selected from a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, or a combination thereof;
adjacent substituents Rx、Ry1、Ry3Can optionally be linked to form a ring;
substituent RzCan optionally be linked to form a ring;
and represents the position of the substituent with the structure of the formula 2 connected with the formula 1.
In this example, the substituent R in formula 11To R10At least one of them has a structure represented by formula 2, and R1To R10The remainder of (a) are selected, identically or differently on each occurrence, from the group consisting of the substituents mentioned above. For example, when the substituent R1Having a structure represented by formula 2, then R1To R10The remainder of (1), namely R2To R10Each occurrence is selected, identically or differently, from the group consisting of the substituents mentioned above. When the substituent R is1And R6Having a structure represented by formula 2, then R1To R10The remainder of (1), namely R2To R5And R7To R10Each occurrence is selected, identically or differently, from the group consisting of the substituents mentioned above.
In this embodiment, the adjacent substituents Rx、Ry1、Ry3The optional attachment to form a ring includes the following: one case is when X1-X3A plurality of them are selected from CRxWhen adjacent to RxCan be connected to form a ring,for example X1And X2Selected from the group consisting of CRxWhen adjacent to RxMay be linked to form a ring; x1And X3Selected from the group consisting of CRxWhen adjacent to RxMay be linked to form a ring; x2And X3Selected from the group consisting of CRxWhen adjacent to RxMay be joined to form a ring. When Y is1And Y5Selected from the group consisting of CRy1,Y2-Y4A plurality of them are selected from CRy3When adjacent substituent Ry3May be linked to form a ring and/or an adjacent substituent Ry1And Ry3May be linked to form a ring, e.g. Y2And Y3Are all selected from CRy3When two R are presenty3May be linked to form a ring; y is3And Y4Are all selected from CRy3When two R are presenty3May be linked to form a ring; y is1Selected from the group consisting of CRy1And Y is2Selected from the group consisting of CRy3At this time Ry1And Ry3May be linked to form a ring; y is5Selected from the group consisting of CRy1And Y is4Selected from the group consisting of CRy3At this time Ry1And Ry3May be joined to form a ring. In another case adjacent substituents Rx、Ry1、Ry3Are not connected to form a ring.
In this example, the "substituent R" iszOptionally joined to form a ring "may comprise any one or more of the following: in one case for the substituent RzIn which there is a connection to form a ring, e.g. when two or more R's are present simultaneouslyzWhen R is equal tozIn which there is a connection to form a ring, e.g. RzThe two are connected to form a ring to form a spiral ring or bridge ring structure. Another case is for the substituent RzMay not be connected to form a ring.
The compound disclosed by the invention is in the N-meta position or N-para position of one aryl group of the arylamine, namely Y in the formula 22-Y4At least one of the aryl groups is substituted by (hetero) aryl, and the device performance can be improved by applying the aryl group to an organic electroluminescent device; on the basis of which it is possible to further position the aryl group in the N-ortho position, i.e. Y in formula 2 according to the invention1And/or Y5And (cyclo) alkyl substitution is introduced, so that the device performance can be further improved. Y in the invention1And/or Y5When the material is unsubstituted or substituted by (cyclo) alkyl, the performance of the device is improved, and the evaporation temperature of the material is mild, relatively speaking, such as Y1And/or Y5Is substituted by (hetero) aryl, and the deposition temperature thereof becomes high, which is disadvantageous in thermal stability required for materials by industry.
According to one embodiment of the invention, wherein the substituent R1To R10At least two of which have the structure of formula 2.
According to one embodiment of the invention, wherein the substituent R1To R10Two of which have the structure of formula 2.
According to one embodiment of the invention, wherein the substituent R1And R6Has the structure of formula 2.
According to one embodiment of the invention, wherein the substituent R2,R4-R5,R7And R9-R10Is a hydrogen atom, a substituent R3And R8Each occurrence, identically or differently, is selected from hydrogen, deuterium, a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, or a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms.
According to one embodiment of the invention, wherein L, identically or differently at each occurrence, is selected from a single bond, a substituted or unsubstituted arylene group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroarylene group having 3 to 30 carbon atoms, or a combination thereof.
According to one embodiment of the invention, wherein L, identically or differently at each occurrence, is selected from a single bond, a substituted or unsubstituted arylene group having 6 to 12 carbon atoms, a substituted or unsubstituted heteroarylene group having 3 to 12 carbon atoms, or a combination thereof.
According to one embodiment of the invention, wherein L is a single bond.
According to one embodiment of the present invention, wherein X1To X3Selected from CR, identically or differently at each occurrencex,Y1And Y5Identical in each occurrence orAre differently selected from CRy1,Y2-Y4Selected from CR, identically or differently at each occurrencey2And CRy3And Y is2-Y4At least one of which is CRy2
RxAnd Ry3Each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amino, acyl, carbonyl, carboxylic acid group, ester group, cyano, isocyano, mercapto, sulfinyl, sulfonyl, phosphino, and combinations thereof, having from 0 to 20 carbon atoms;
Ry1each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, and combinations thereof;
Ry2each occurrence, identically or differently, is selected from a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, or a combination thereof;
adjacent substituents Rx、Ry1、Ry3Can optionally be linked to form a ring.
According to one embodiment of the invention, wherein RxEach occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, substituted or unsubstituted alkyl having 3 to 20 ring carbonsAn atomic cycloalkyl group, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, and combinations thereof.
According to one embodiment of the invention, wherein RxEach occurrence, identically or differently, is selected from hydrogen, deuterium, fluoro, methyl, ethyl, isopropyl, cyclopentyl, cyclohexyl, phenyl, methylphenyl, isopropylphenyl, or a combination thereof.
According to one embodiment of the present invention, wherein Y2-Y4Selected from CR, identically or differently at each occurrencey2And CRy3And Y is2-Y4At least one of which is CRy2The balance being CRy3
In this embodiment, "Y2-Y4At least one of which is CRy2The balance being CRy3"includes the following cases: when Y is2-Y4One of them is CRy2When the other two are CRy3(ii) a When Y is2-Y4Two of them are CRy2When the remaining one is CRy3(ii) a Or Y2-Y4Are all CRy2. For example when Y2Is CRy2When it is, then Y3And Y4Is CRy3(ii) a When Y is3Is CRy2When it is, then Y2And Y4Is CRy3(ii) a When Y is4Is CRy2When it is, then Y1And Y3Is CRy3(ii) a When Y is2And Y4Is CRy2When it is, then Y3Is CRy3(ii) a When Y is3And Y4Is CRy2When it is, then Y2Is CRy3;Y2、Y3、Y4Are all CRy2
According to one embodiment of the present invention, wherein Y2-Y4Selected from CR, identically or differently at each occurrencey2And CRy3And Y is2-Y4One of them is CRy2The balance being CRy3
According to one embodiment of the invention, wherein Ry3Selected from hydrogen, identically or differently at each occurrence,deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 6 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 6 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 6 carbon atoms, substituted or unsubstituted aryl groups having 6 to 12 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 12 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 6 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 12 carbon atoms, and combinations thereof.
According to one embodiment of the invention, wherein Ry3Each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, fluoro, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, n-butyl, isobutyl, tert-butyl, cyclopentyl, cyclohexyl, phenyl, trimethylsilyl, and combinations thereof.
According to one embodiment of the invention, wherein Ry2Each occurrence, identically or differently, is selected from a substituted or unsubstituted aryl group having 6 to 24 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 24 carbon atoms, or a combination thereof.
According to one embodiment of the invention, wherein Ry2Each occurrence, identically or differently, is selected from a substituted or unsubstituted aryl group having 6 to 18 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 18 carbon atoms, or a combination thereof.
According to one embodiment of the invention, wherein Ry2Each occurrence, identically or differently, is selected from a substituted or unsubstituted aryl group having 6 to 12 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 12 carbon atoms, or a combination thereof.
According to one embodiment of the invention, wherein Ry2Each occurrence identically or differently selected from phenyl, 2-methylphenyl, 2-ethylphenyl, 2-isopropylphenyl, 2-tert-butylphenyl, biphenyl, terphenyl, quaterphenyl, triphenylene, tetraphenylene, 2-naphthyl, phenanthrene, anthracene, indene, fluorene, indole, carbazole, benzofuran, dibenzofuran, benzothiole, dibenzothiaole, benzothiophene, dibenzothiophene, dibenzoselenophene, deuterated 2-methylphenyl, deuterated 2-ethylphenyl, deuterated 2-isopropylphenyl,deuterated 2-tert-butylphenyl, or a combination thereof.
According to one embodiment of the present invention, wherein Y1And Y5Selected from CR, identically or differently at each occurrencey1And said R isy1Each occurrence, identically or differently, is selected from a substituted or unsubstituted alkyl group having 1 to 12 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 12 ring carbon atoms, or a combination thereof.
According to one embodiment of the present invention, wherein Y1And Y5Selected from CR, identically or differently at each occurrencey1And said R isy1Each occurrence, identically or differently, is selected from a substituted or unsubstituted alkyl group having 1 to 6 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 6 ring carbon atoms, or a combination thereof.
According to one embodiment of the present invention, wherein Y1And Y5Selected from CR, identically or differently at each occurrencey1And said R isy1Each occurrence, identically or differently, is selected from hydrogen, deuterium, fluorine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, n-butyl, isobutyl, tert-butyl, cyclopentyl, neopentyl, cyclohexyl, deuterated methyl, deuterated ethyl, deuterated n-propyl, deuterated isopropyl, deuterated cyclopropyl, deuterated n-butyl, deuterated isobutyl, deuterated tert-butyl, deuterated cyclopentyl, deuterated neopentyl, deuterated cyclohexyl, or a combination thereof.
According to one embodiment of the invention, wherein Z is C (R)z)2And said R iszEach occurrence, the same or different, is selected from hydrogen, deuterium, halogen, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl having 3 to 20 carbon atoms, or combinations thereof.
According to one embodiment of the invention, wherein RzEach occurrence, identically or differently, is selected from the group consisting of hydrogen, halogen, deuterium, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, n-butyl, isobutyl, tert-butylButyl, cyclopentyl, cyclohexyl, or combinations thereof.
According to one embodiment of the invention, wherein Rx、Ry1And Ry3At least one of which is fluorine.
According to one embodiment of the present invention, wherein the compound is selected from the group consisting of compound BD1 through compound BD1267, the specific structures of compound BD1 through compound BD1267 are shown in claim 13.
According to an embodiment of the present invention, there is also disclosed an electroluminescent device including:
an anode, a cathode, a anode and a cathode,
a cathode electrode, which is provided with a cathode,
and an organic layer disposed between the anode and the cathode, the organic layer comprising a compound having formula 1:
Figure BDA0002495366720000111
wherein, in the formula 1,
substituent R1-R10At least one of which has the structure of formula 2:
Figure BDA0002495366720000121
and the substituent Rl-Rl0The remaining of (a) are, identically or differently on each occurrence, selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl having 2 to 20 carbon atoms, substituted or unsubstituted aryl having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl having 3 to 20 carbon atomsAlkylsilyl, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amino groups having 0 to 20 carbon atoms, acyl groups, carbonyl groups, carboxylic acid groups, ester groups, cyano groups, isocyano groups, mercapto groups, sulfinyl groups, sulfonyl groups, phosphino groups, and combinations thereof;
wherein, in the formula 2,
l is selected from a single bond, a substituted or unsubstituted arylene group having 6 to 60 carbon atoms, a substituted or unsubstituted heteroarylene group having 3 to 60 carbon atoms, or a combination thereof;
X1-X3is CRxOr N;
Y1and Y5Selected from CR, identically or differently at each occurrencey1Or N;
Y2-Y4selected from CR, identically or differently at each occurrencey2、CRy3Or N, and Y2-Y4At least one of which is CRy2
Z is selected, identically or differently on each occurrence, from C (R)z)2,NRzO, S or Se;
Rx、Ry3and RzEach occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amino, acyl, carbonyl, carboxylic acid group, ester group, cyano, isocyano, mercapto, sulfinyl, sulfonyl, phosphino, and combinations thereof, having from 0 to 20 carbon atoms;
Ry1each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, and combinations thereof;
Ry2each occurrence, identically or differently, is selected from a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, or a combination thereof;
adjacent substituents Rx、Ry1、Ry3Can optionally be linked to form a ring;
substituent RzCan optionally be linked to form a ring;
and represents the position of the substituent with the structure of the formula 2 connected with the formula 1.
According to one embodiment of the present invention, wherein the organic layer in the organic electroluminescent device comprises a light emitting layer, wherein the light emitting layer comprises the compound having formula 1.
According to one embodiment of the present invention, wherein the light emitting layer further comprises a compound having formula 3:
Figure BDA0002495366720000122
wherein, in the formula 3,
Rg1to Rg8Each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl having 2 to 20 carbon atoms, substituted or unsubstituted aryl having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl having 3 to 20 carbon atoms-an alkylsilyl group of 20 carbon atoms, a substituted or unsubstituted arylsilyl group of 6 to 20 carbon atoms, a substituted or unsubstituted amino group of 0 to 20 carbon atoms, an acyl group, a carbonyl group, a carboxylic acid group, an ester group, a cyano group, an isocyano group, a mercapto group, a sulfinyl group, a sulfonyl group, a phosphino group, and combinations thereof;
Rg9and Rg10Each occurrence, identically or differently, is selected from substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, or substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms.
According to one embodiment of the invention, a compound formula is also disclosed, which comprises a compound with a structure shown in formula 1, wherein the specific structure of the compound is shown in any embodiment.
In combination with other materials
The materials described herein for use in particular layers in an organic light emitting device may be used in combination with various other materials present in the device. Combinations of these materials are described in detail in U.S. patent application Ser. No. 0132-0161 of U.S. 2016/0359122A1, the entire contents of which are incorporated herein by reference. The materials described or referenced therein are non-limiting examples of materials that may be used in combination with the compounds disclosed herein, and one skilled in the art can readily review the literature to identify other materials that may be used in combination.
Materials described herein as being useful for particular layers in an organic light emitting device can be used in combination with a variety of other materials present in the device. For example, the light emitting dopants disclosed herein may be used in conjunction with a variety of hosts, transport layers, barrier layers, injection layers, electrodes, and other layers that may be present. Combinations of these materials are described in detail in U.S. patent application Ser. No. US2015/0349273A1, paragraph 0080-0101, the entire contents of which are incorporated herein by reference. The materials described or referenced therein are non-limiting examples of materials that may be used in combination with the compounds disclosed herein, and one skilled in the art can readily review the literature to identify other materials that may be used in combination.
In the examples of material synthesis, all reactions were carried out under nitrogen unless otherwise stated. All reaction solvents were anhydrous and used as received from commercial sources. The synthesis product is subjected to structural validation and characterization using one or more equipment conventional in the art (including, but not limited to, Bruker's nuclear magnetic resonance apparatus, Shimadzu's liquid chromatograph-mass spectrometer, gas chromatograph-mass spectrometer, differential scanning calorimeter, Shanghai prism-based fluorescence spectrophotometer, Wuhan Corset's electrochemical workstation, Anhui Beidek's sublimator, etc.) in a manner well known to those skilled in the art. In an embodiment of the device, the device characteristics are also tested using equipment conventional in the art (including, but not limited to, an evaporator manufactured by Angstrom Engineering, an optical test system manufactured by Fushida, Suzhou, an ellipsometer manufactured by Beijing Mass., etc.) in a manner well known to those skilled in the art. Since the relevant contents of the above-mentioned device usage, testing method, etc. are known to those skilled in the art, the inherent data of the sample can be obtained with certainty and without being affected, and therefore, the relevant contents are not described in detail in this patent.
Materials synthesis example:
the preparation method of the compound of the present invention is not limited, and the following compounds are typically but not limited to, and the synthetic route and the preparation method thereof are as follows:
synthesis example 1: synthesis of Compound BD32
The first step is as follows:
Figure BDA0002495366720000131
LDA (100mL,200mmol) was placed in a 250mL three-necked flask, stirred under dry ice-ethanol for half an hour, methyl isobutyrate (23mL, 200mmol) was added, and stirring was continued for half an hour. 1-bromo-2- (bromomethyl) benzene (25g, 100mmol) was added and filtered through celite. After concentration, a crude product intermediate 1 is obtained and directly subjected to the next reaction.
The second step is that:
Figure BDA0002495366720000141
intermediate 1(27g, 100mmol) and potassium hydroxide (56g, 1mol) were mixed, 100mL of water and 10mL of methanol were added, and the mixture was heated to 100 ℃ for reaction until the TLC detection reaction was completed. Cooling, adding concentrated hydrochloric acid to adjust system pH to acidity after reaction returns to room temperature, extracting organic phase with ethyl acetate, combining organic phases, and concentrating.
Dissolve the above product (27g, 100mmol) in 200mL of dichloromethane, N2Bubbling, adding one drop of DMF, gradually adding oxalyl chloride (12.8mL, 120mmol) dropwise, after the system generates no more bubbles, moving the reaction to an ice bath, stirring for half an hour, adding aluminum trichloride (14.3g, 108mmol) in batches, and monitoring by TLC until the reaction is finished. Purification by column chromatography eluting with PE gave intermediate 2 as a white solid (22g,91.6mmol, 85% yield).
The third step:
Figure BDA0002495366720000142
intermediate 2(22g, 99mmol) was dissolved in 300mL of methanol, stirred in an ice-water bath for half an hour and NaBH was added in portions4After completion of the reaction, the reaction mixture was filtered through celite, and the filtrate was concentrated.
The product was dissolved in dichloromethane and Et was added3SiH (22.5g, 198mmol), stirred in an ice-water bath for half an hour, gradually added TFA (34g,297mmol) dropwise, concentrated, and purified by column chromatography to give intermediate 3 as a colorless oil (7.7g,34.4mmol, 35% yield).
The fourth step:
Figure BDA0002495366720000143
pd is added at room temperature under the protection of nitrogen2(dba3) (1g,1.1mmol), intermediate 3(5.1g, 22.7mmol), 4-methyl- [1,1' -biphenyl]3-amine (5g, 27.2mmol), BINAP (1.4g,2.2mmol) and tBuONa (4.7g, 49.6mmol) was added to xylene (100mL) and the system was heated to 90 deg.C for reaction overnight. After the reaction was completed, purification was performed by column chromatography to obtain intermediate 4(5.7g, 17.4mmol, yield 76%) as a white solid.
The fifth step:
Figure BDA0002495366720000144
under the protection of nitrogen at room temperature, 1, 6-dibromopyrene (2.6g, 7.2mmol), intermediate 4(5.7g, 17.4mmol), Pd (OAc)2(161mg,0.72mmol),tBu3PH+BF4 -(406mg, 1.4mmol) and tBuONa (2.7g, 28.2mmol) were added to xylene (20mL) and the system was heated to 100 ℃ until the reaction was complete. And purified by column chromatography to give the compound BD32 as a yellow-green solid (1.2g, 1.41mmol, 20% yield). The product was identified as the target product with a molecular weight of 852.4.
Synthesis example 2: synthesis of Compound BD1141
First step of
Figure BDA0002495366720000151
2-bromo-4-iodo-1-methylbenzene (100g, 337mmol), phenylboronic acid (49g, 404mmol), Pd (PPh)3)4(7.8g,6.8mmol),K2CO3(116g, 843mmol) was placed in a 1000mL three-necked flask, and 340mL of toluene, 110mL of THF, and H were added2O110 mL, replacement of N2. Heating to 78 ℃ for reaction. The reaction is carried out until the raw material is completely reacted, and column chromatography purification is carried out to obtain the intermediate 5(80g, 325mmol, 97% yield) as colorless oily liquid.
Second step of
Figure BDA0002495366720000152
Intermediate 5(81g, 329mmol), NBS (61g, 345mmol) was placed in a 2L two-necked flask and 1.3L acetonitrile was added to replace N2Heating ofThe reaction is stirred to 80 ℃. Benzoyl peroxide (8g, 33mmol) was added portionwise. The reaction was carried out until the starting material was completely reacted, and column chromatography purification was carried out to obtain intermediate 6(82g, 253mmol, yield 77%) as a white solid.
The third step
Figure BDA0002495366720000153
LDA (130mL, 260mmol) was placed in a 500mL three-necked flask, stirred under dry ice-ethanol for half an hour, methyl isobutyrate (30mL, 260mmol) was added, and stirring was continued for half an hour. Intermediate 6(48g, 148mmol) was added. The reaction is carried out until the raw materials completely react, and column chromatography purification is carried out to obtain the product, namely the intermediate 7(50g, 145mmol, 98% yield) which is light yellow oily matter.
The fourth step
Figure BDA0002495366720000154
Intermediate 7(78g, 227mmol), KOH (88g, 1.57mol) were mixed and H was added2O (230mL), methanol (23mL), was heated to 100 ℃ for reaction until the reaction was complete by TLC. After cooling and the reaction returned to room temperature, concentrated HCl was added to adjust the pH of the system to acidic and the precipitated white solid was filtered to give intermediate (71g, 227 mmol).
The intermediate (20g, 60mmol) was dissolved in 200mL of dichloromethane, and N was passed through the solution2Adding one drop of DMF, gradually adding oxalyl chloride (30mL, 60mmol) dropwise, after the system generates no more bubbles, moving the reaction to an ice water bath for stirring for half an hour, adding aluminum trichloride (8g, 60mmol) in batches, and monitoring by TLC until the reaction is finished. Filtered through celite and concentrated. Column chromatography gave intermediate 8 as a white solid (6g,18.8mmol, 31% yield).
The fifth step
Figure BDA0002495366720000161
Intermediate 8 (1)8g, 57mmol) in methanol (180mL), stirring for half an hour in an ice water bath, and adding NaBH in portions4After completion of the reaction, the reaction mixture was filtered through celite, and the filtrate was concentrated.
The product was dissolved in dichloromethane and Et was added3SiH (12.7g, 111mmol) was stirred in an ice water bath for half an hour, and TFA (18g, 155mmol) was gradually added dropwise to react until the starting material completely reacted, and column chromatography purification was performed to obtain intermediate 9(12g, 39.9mmol, yield 70%) as a colorless oil.
The sixth step
Figure BDA0002495366720000162
Pd is added at room temperature under the protection of nitrogen2(dba)3(910mg,0.99mmol), BINAP (1.18g,1.99mmol), intermediate 9(6g,19.9mmol), [1,1' -Biphenyl]-3-amine (5.5g, 30mmol) and tBuONa (3.8g,39.8mmol) were added to toluene (100mL) and the system was heated to 120 ℃ for 2 h. After the reaction was completed, purification was performed by column chromatography to obtain intermediate 10(6.7g,16.4mmol, 83% yield) as a colorless oil.
Seventh step
Figure BDA0002495366720000163
Under the protection of nitrogen at room temperature, 1, 6-dibromopyrene (2.2g,6.1mmol), intermediate 10(5.5g,14mmol), Pd (OAc)2(68mg,0.3mmol),tBu3PH+BF4 -(174mg,0.6mmol) and tBuONa (1.3g,14mmol), xylene (30mL) was added and the system was heated to 95 ℃. After the reaction was completed, purification was performed by column chromatography to obtain BD1141(5g,5.1mmol, yield 84%) as a yellow-green solid. The product was identified as the target product with a molecular weight of 976.5.
Synthetic example 3: synthesis of Compound BD151
First step of
Figure BDA0002495366720000164
Under the protection of nitrogen at-78 ℃, adding the intermediate 11(50g, 139mmol) into a 1L single-neck bottle, adding THF (400mL), dropwise adding iPrMgCl (84mL,167mmol), dropwise adding pivalaldehyde (36g, 418mmol) after half an hour, and heating to room temperature after dropwise adding. The reaction system was quenched with ammonium chloride, extracted with DCM, and the solvent removed to give an intermediate. The intermediate was dissolved in DCM (1400mL) and the system was cooled to 0 deg.C and Et was added3SiH (24g, 213mmol), TFA (36g, 320mmol) was added dropwise half an hour later and the reaction was allowed to warm to room temperature. After the reaction was completed, purification was performed by column chromatography to obtain intermediate 12(36g, 118mmol, yield 85%) as a crude colorless oil.
Second step of
Figure BDA0002495366720000171
Pd (OAc) at room temperature under the protection of nitrogen2(0.5g, 2.2mmol), intermediate 3(10g, 44.2mmol), benzophenone imine (8.8g, 48.7mmol), dppf (2.4g,4.4mmol) and tBuONa (8.8g,88.4mmol) were added to a 250mL one-neck flask, o-xylene (100mL) was added and the system was heated to 90 ℃ for reaction overnight. The reaction solution was treated with basic alumina and MgSO4Filtration and washing with Tol removed the solvent to give the crude product which was crystallized from PE to give the intermediate. The intermediate was dissolved in THF (30mL), HCl (10mL) was added and the reaction was allowed to proceed overnight. After the reaction was completed, purification was performed by column chromatography to obtain intermediate 13(6.2g,38.5mmol, yield 87%) as a white solid.
The third step
Figure BDA0002495366720000172
Pd is added at room temperature under the protection of nitrogen2(dba)3(0.5g,0.55mmol), intermediate 12(4g, 13.2mmol), intermediate 13(2.6g,16.1mmol), BINAP (685mg,1.1mmol) and tBuONa (2.8g,29.1mmol) were added to xylene (100mL) and the system was heated to 90 ℃ for reaction overnight. After the reaction is finished, the white solid is obtained by column chromatography purificationIntermediate 14(4.5g, 11.7mmol, 88% yield).
The fourth step
Figure BDA0002495366720000173
Under the protection of nitrogen at room temperature, intermediate 14(4g, 10.4mmol), 1, 6-dibromopyrene (1.56g, 4.35mmol), Pd (OAc)2(63mg,0.28mmol),tBu3PH+BF4 -(162mg, 0.56mmol) and tBuONa (3.2g,33mmol) were added to xylene (30mL) and the system was heated to 100 ℃ until the reaction was complete. After the completion of the reaction, purification was performed by column chromatography to obtain BD151 as a yellow-green solid compound (1.1g,1.14mmol, 26% yield). The product was identified as the target product with a molecular weight of 964.6.
Synthetic example 4: synthesis of Compound BD250
First step of
Figure BDA0002495366720000174
Palladium acetate (0.15g, 0.67mmol), BINAP (0.83g, 1.32mmol) was added to toluene (70.0mL) at room temperature under nitrogen. Introducing N into the solution2After 20 min, intermediate 3(5.0g, 22.12mmol), 5-fluoro- [1,1' -biphenyl, were added]-3-amine (4.3g,23.23mmol), sodium tert-butoxide (6.4g,66.37 mmol). Continuously introducing N2After 10 minutes, the system was heated to 110 ℃ for 4 hours. After the reaction was completed, purification was performed by column chromatography to obtain intermediate 15(3.8g,11.41mmol, yield 52%) as a pale yellow oil.
Second step of
Figure BDA0002495366720000181
At room temperature under the protection of nitrogen, palladium acetate (35mg,0.16mmol), tBu3PH+BF4 -(91mg, 0.32mmol) xylene (40.0mL) was added. Introducing N into the solution2The reaction time is 20 minutes and the reaction time is 20 minutes,1, 6-dibromopyrene (2g, 5.56mmol), intermediate 15(3.8g,11.41 mmol), sodium tert-butoxide (2.1g, 22.2mmol) were added successively. Continuously introducing N2After 10 minutes, the system was heated to 95 ℃ until the reaction was complete. After the reaction was completed, purification was performed by column chromatography to obtain BD250(4g, 4.64mmol, 84% yield) as a yellow solid. The product was identified as the target product with a molecular weight of 860.4.
Synthesis example 5: synthesis of Compound BD441
First step of
Figure BDA0002495366720000182
Under the protection of nitrogen at 0 ℃, 2-methyl-5-fluoronitrobenzene (200g, 1.29mol) is dissolved in sulfuric acid, NBS (252g, 1.42mol) is added in portions, and the mixture is warmed to room temperature for reaction. After the reaction was completed, purification was performed by column chromatography to obtain intermediate 16(220g, 936mmol, yield 72%) as a yellow liquid.
Second step of
Figure BDA0002495366720000183
Intermediate 16(50g, 213mmol), Fe (35g, 638mmol) and NH were added at room temperature4C1(1.1g, 21.3mmol) was charged into a 1L one-necked flask, EtOH (400mL), water (100mL) were added, and the system was heated to 90 ℃ for reaction. After the completion of the reaction, column chromatography was performed to obtain intermediate 17(41g, 200mmol, yield 94%) as a pale yellow liquid.
The third step
Figure BDA0002495366720000184
Pd (PPh) is added at room temperature under the protection of nitrogen3)4(3.4g, 3mmol), intermediate 17(31g, 151mmol), 2-methylphenylboronic acid (21g, 159mmol) and K2CO3(52g, 378mmol) was put into a 1L one-necked flask, toluene (400mL), EtOH (200mL), and water (100mL) were added, and the system was heated to 90 ℃ to reactOvernight. The system was heated to 90 ℃ and reacted overnight. After the reaction was completed, column chromatography was performed to obtain intermediate 18(27g, 125mmol, 83% yield) as a pale yellow solid.
The fourth step
Figure BDA0002495366720000191
Pd is added at room temperature under the protection of nitrogen2dba3(0.5g,0.55mmol), intermediate 18(5.7g, 26.5mmol), intermediate 3(5g,22mmol), BINAP (685mg,1.1mmol) and tBuONa (8.3g,86.9mmol) were added to a 250mL single vial, xylene (100mL) was added and the system was heated to 90 ℃ for reaction overnight. After the reaction was completed, column chromatography was performed to obtain intermediate 19(7.3g, 20.2mmol, 91% yield) as a white solid.
The fifth step
Figure BDA0002495366720000192
At room temperature under the protection of nitrogen, intermediate 19(7.3g, 20mmol), 1, 6-dibromopyrene (3g, 8.4mmol), Pd (OAc)2(63mg,0.28mmol),tBu3PH+BF4 -(162mg, 0.56mmol) and tBuONa (3.2g,33mmol) were added to xylene (30mL) and the system was heated to 100 ℃ until the reaction was complete. After the reaction was completed, the product was separated by column chromatography to obtain BD441 as a yellow-green solid (1.2g, 1.30mmol, yield 15.4%). The product was identified as the target product and had a molecular weight of 916.5.
Synthetic example 6: synthesis of Compound BD1148
First step of
Figure BDA0002495366720000193
Pd is added at room temperature under the protection of nitrogen2(dba)3(9l0mg, 0.99mmol), BINAP (1.18g,1.99mmol), intermediate 9(6g,19.9mmol), 4-methyl- [1,1' -biphenyl]-3-amine (5.5g, 30mmol) and t-BuONa (b3.8g,39.8mmol) was added toluene (100mL) and the system was heated to 120 ℃ for 2 h. After the reaction was completed, purification was performed by column chromatography to obtain intermediate 20(6.7g, 16.4mmol, yield 82.7%) as a white solid.
Second step of
Figure BDA0002495366720000201
Under the protection of nitrogen at room temperature, 1, 6-dibromopyrene (2.38g, 6.6mmol), intermediate 6(6.2g, 15.2mmol), Pd (OAc)2(74mg,0.33mmol),t-Bu3P·H+BF4 -(191mg,0.66mmol) and t-BuONa (1.46g,15.2mmol), xylene (33mL) was added and the system was heated to 95 ℃. After the reaction was completed, the product compound BD1148(6g,5.97mmol, yield 90%) was obtained by column chromatography purification. The product was identified as the target product with a molecular weight of 1004.5.
Synthetic example 7: synthesis of Compound BD257
First step of
Figure BDA0002495366720000202
Pd (PPh) is added at room temperature under the protection of nitrogen3)4(3.4g, 3mmol), intermediate 17(55g, 268mmol), phenylboronic acid (50g,282mmol) and K2CO3(92g, 670mmol) was added to a 1L one-necked flask, Tol (400mL), EtOH (200mL), water (100mL) was added, and the system was heated to 90 ℃ for reaction overnight. After the reaction was completed, intermediate 21(42g,208mmol, yield 77%) was obtained as a pale yellow solid by column chromatography.
Second step of
Figure BDA0002495366720000203
Pd is added at room temperature under the protection of nitrogen2(dba)3(0.5g,0.55mmol), intermediate 21(5.4g, 26.2mmol), intermediate 3(5g,22mmol), BINAP (685mg,1.1mmol) and tBuONa (8.3g,86.9mmol) was added to a 250mL single neck flask, xylene (100mL) was added and the system was heated to 90 ℃ and reacted overnight. After the reaction was completed, column chromatography was performed to obtain intermediate 22(5.8g,16.7mmol, yield 76%) as a white solid.
The third step
Figure BDA0002495366720000204
Under the protection of nitrogen at room temperature, intermediate 22(5.8g,16.7mmol), 1, 6-dibromopyrene (2.5g,7.0mmol), Pd (OAc)2(63mg,0.28mmol),tBu3PH+BF4 -(162mg, 0.56mmol) and tBuONa (3.2g,33mmol) were added to a 100mL single neck flask, xylene (30mL) was added and the system was heated to 100 ℃ until the reaction was complete. After completion of the reaction, the compound BD257 was obtained as a yellow-green solid (1.4g,1.57mmol, 22% yield) by column chromatography. The product was identified as the target product with a molecular weight of 888.4.
Synthesis example 8: synthesis of Compound BD261
First step of
Figure BDA0002495366720000211
1-bromo-2-fluoro-4-methylbenzene (94.5g, 0.5mol) was dissolved in 1L of concentrated sulfuric acid at 0 ℃ and concentrated nitric acid (37.8g,0.6mol) was slowly added dropwise. The reaction was allowed to warm to room temperature and stirred overnight. After completion of the reaction, a large amount of ice was added, followed by extraction with dichloromethane three times, and the organic phases were combined and separated by column chromatography to give intermediate 23(93.6g,0.4mol, yield 80%).
Second step of
Figure BDA0002495366720000212
Under nitrogen protection, intermediate 23(26.8g, 114.6mmol), phenylboronic acid (21g,172mmol), tetrakis (triphenylphosphine) palladium (6.7g, 5.74mmol), K were added to a dry 1L three-necked flask2CO3(47.5g,344mmol), toluene (240mL) and water (60mL) were purged with nitrogen three times, warmed to 100 ℃ overnight, the reaction was stopped, and separated by column chromatography to give intermediate 24(23.1g,100mmol, 89% yield).
The third step
Figure BDA0002495366720000213
Intermediate 24(23.1g,100 mmol) was dissolved in 1L of ethanol, and 100mL of saturated aqueous ammonium chloride was added. After addition of reduced iron powder (16.8g, 300mmol), the reaction was warmed to 80 ℃ and stirred for 3 hours. After cooling to room temperature, the reaction solution was filtered through celite, after evaporating off most of the ethanol, water was added, extraction was carried out three times with dichloromethane, and the organic phases were combined. Purification by column chromatography gave intermediate 25(19g, 95mmol, 95% yield).
The fourth step
Figure BDA0002495366720000214
Pd is added at room temperature under the protection of nitrogen2(dba)3(910mg,0.99mmol), BINAP (1.18g,1.99mmol), intermediate 25(6.03g, 30mmol), intermediate 3(4.48g,19.9mmol), and tBuONa (3.8g,39.8mmol) were added to toluene (200mL) and the system was heated to 120 ℃ for 2 h. After the reaction was completed, purification was performed by column chromatography to obtain intermediate 26(5.52g,16mmol, 53% yield) as a colorless oil.
The fifth step
Figure BDA0002495366720000221
Under the protection of nitrogen at room temperature, 1, 6-dibromopyrene (2.2g,6.1mmol), intermediate 26(5.52g,16 mmol), Pd (OAc)2(68mg,0.3mmol),tBu3PH+BF4 -(174mg,0.6mmol) and t-BuONa (1.3g,14mmol), xylene (30mL) was added and the system was heated to 95 ℃. After the reaction is finishedPurification by column chromatography gave BD261 as a yellow-green solid (2g, 2.25mmol, 37% yield). The product was identified as the target product with a molecular weight of 888.4.
Synthetic example 9: synthesis of Compound BD177
First step of
Figure BDA0002495366720000222
2-bromo-4-fluoro-1-methylbenzene (120g, 634.9mmol), benzoyl peroxide (8g33mmol) were added to acetonitrile (1.5L) at room temperature, NBS (124g, 698.4mmol) was added in portions, heated to 80 ℃ and stirred. Purification by column chromatography after completion of the reaction gave intermediate 27(136g,507.46mmol, 80% yield) as a white solid.
Second step of
Figure BDA0002495366720000223
LDA (2M, 380mmol) was added to tetrahydrofuran (300mL), stirred under dry ice-ethanol for half an hour, methyl isobutyrate (87mL, 761.19mmol) was added dropwise, and after stirring for another half an hour, intermediate 27(136.0g, 507.46mmol in THF 200mL) was added dropwise. After the reaction was complete, water was added and quenched, extracted with ethyl acetate, the organic phase was concentrated and dissolved in methanol (800ml), KOH (78g, 1402mmol in H) was added2O400 ml), heated to 40 ℃ to react, and purified by column chromatography after completion of the reaction to give intermediate 28(116g, 415.77mmol, 82% yield) as a pale yellow oil.
The third step
Figure BDA0002495366720000224
Under the protection of nitrogen at 0 ℃, dissolving the intermediate 28(116g, 415.77mmol) in 500mL dichloromethane, adding N, N-dimethylformamide (0.5mL), gradually dropwise adding thionyl chloride (32mL, 436.56mmol), reacting at 0 ℃ for 2h, concentrating, adding the concentrated system into 500mL dichloromethane, adding aluminum trichloride (55g, 415.77mmol) at 0 ℃, then returning to room temperature for reaction, adding water after the reaction is complete, quenching, and separating. The organic phase was concentrated and purified by column chromatography to give intermediate 29 as a clear oil (40.0g,155.64mmol, 37% yield).
The fourth step
Figure BDA0002495366720000231
Intermediate 29(55g, 214.0lmmol) was dissolved in 500mL of methanol at 0 deg.C under nitrogen, sodium borohydride (9.7g, 256.8mmol) was added in portions until the reaction was complete, the mixture was filtered through celite, and the filtrate was concentrated.
The above product was dissolved in dichloromethane, triethylsilane (62.0g, 470.0mmol) was added, stirred for half an hour in an ice water bath, trifluoroacetic acid (60ml,810.8mmol) was gradually added dropwise, reacted at room temperature for 72h and concentrated, and purified by column chromatography to give intermediate 30(7.0g,28.92mmol, 14% yield) as a pale yellow oil.
The fifth step
Figure BDA0002495366720000232
Palladium acetate (148.0mg, 0.67mmol), BINAP (826.0mg, 1.32mmol), 4-methyl- [1,1' -biphenyl ] -3-amine (4.3g,23.23mmol), intermediate 30(5.0g,22.12mmol) and sodium tert-butoxide (6.4g,66.37mmol) were added to a 250mL one-neck flask under nitrogen at room temperature, toluene (100mL) was added, and the system was heated to 120 ℃ for 2 h. After the reaction was completed, purification was performed by column chromatography to obtain intermediate 31(3.8g,11.41mmol, yield 52%) as a pale yellow oil.
The sixth step
Figure BDA0002495366720000233
At room temperature under the protection of nitrogen, palladium acetate (35mg,0.16mmol), tBu3PH+BF4 -(91mg, 0.32mmol) and dimethyl ether was addedBenzene (40.0 mL). Introducing N into the solution2After 20 min, 1, 6-dibromopyrene (2.0g, 5.56mmol), intermediate 31(3.8g,11.41 mmol), sodium tert-butoxide (2.1g, 22.2mmol) were added successively. Continuously introducing N2For 10 minutes, the system was heated to 95 ℃. After the reaction was completed, purification was performed by column chromatography to obtain BD177(2.0g, 2.25mmol, 40% yield) as a yellow-green solid compound. The product was identified as the target product with a molecular weight of 888.4.
Synthetic example 10: synthesis of Compound BD393
First step of
Figure BDA0002495366720000234
Pd is added at room temperature under the protection of nitrogen2(dba)3(910mg,0.99mmol), BINAP (1.18g,1.99mmol), intermediate 3(5g,22.7mmol), 2 '-4-methyl- [1,1' -biphenyl]-3-amine (5.4g, 27.2mmol) and tBuONa (4.3g,45 mmol) were added to toluene (100mL) and the system was heated to 120 ℃ for 2 h. After the reaction was completed, purification was performed by column chromatography to obtain intermediate 32(5.4g, 15.8mmol, yield 71%) as a colorless oil.
Second step of
Figure BDA0002495366720000241
Under the protection of nitrogen at room temperature, 1, 6-dibromopyrene (2g, 6.28mmol), intermediate 32(4.9g, 14.45mmol), Pd (OAc)2(70mg,0.31mmol),tBu3PH+BF4 -(180mg, 0.62mmol) and tBuONa (1.38g, 14.45mmol), xylene (30mL) was added and the system was heated to 95 ℃. After the reaction was completed, purification was performed by column chromatography to obtain BD393(4g, 4.54mmol, yield 72%) as a yellow-green solid. The product was identified as the target product with a molecular weight of 880.5.
Synthetic example 11: synthesis of Compound BD103
First step of
Figure BDA0002495366720000242
Under nitrogen protection, 1-isopropyl-2-nitrobenzene (25g, 151.3mmol), TFA (500mL), and concentrated sulfuric acid (50mL) were added to a dry 1L single-neck flask, and after dissolution, NBS (27g, 151.3mmol) was added in portions, and the mixture was cooled to 0 ℃ to return to room temperature, and the reaction was completed overnight. Column chromatography gave intermediate 33(28g, 114.6mmol, 75.7% yield).
Second step of
Figure BDA0002495366720000243
Under nitrogen protection, a dry 1L three-necked flask was charged with intermediate 33(28g, 114.6mmol), phenylboronic acid (21g,172mmol), tetrakistriphenylphosphine palladium (6.7g, 5.74mmol), K2CO3(47.5g,344mmol), dioxane (240mL) and water (60mL) were replaced with nitrogen three times, the reaction was stopped after warming to 100 ℃ overnight, and the reaction was separated by column chromatography to give intermediate 34(25g, 102.8mmol, 89.6% yield).
The third step
Figure BDA0002495366720000244
Under nitrogen protection, a dry 1L three-neck flask was charged with intermediate 34(25g, 100mmol), hydrazine hydrate (6g), FeCl3(2.5g), activated carbon (2.5g), toluene (275mL) and ethanol (275 mL). The temperature is increased to 90 ℃ and the mixture is refluxed, hydrazine hydrate (6mL) is added every hour, TLC monitoring is carried out, 42mL of hydrazine hydrate is added in total, and the reaction is completed after 24 hours. Cool down, filter through celite, rinse with DCM, extract and concentrate. Column chromatography isolation gave the title product, intermediate 35(18g,84.5mmol, 84.5% yield).
The fourth step
Figure BDA0002495366720000251
Under the protection of nitrogen at room temperatureNext, Pd is added2(dba)3(910mg,0.99mmol), BINAP (1.18g,1.99mmol), intermediate 35(6.33g,30mmol), intermediate 3(4.48g,19.9mmol), and tBuONa (3.8g,39.8mmol) were added to toluene (200mL) and the system was heated to 120 ℃ for 2 h. After the reaction was completed, purification was performed by column chromatography to obtain intermediate 36(5.8g,16.4mmol, 83% yield) as a colorless oil.
The fifth step
Figure BDA0002495366720000252
Under the protection of nitrogen at room temperature, 1, 6-dibromopyrene (2.2g,6.1mmol), intermediate 36(5.8g,16.4mmol), Pd (OAc)2(68mg,0.3mmol),tBu3PH+BF4 -(174mg,0.6mmol) and tBuONa (1.3g,14mmol), xylene (30mL) was added and the system was heated to 95 ℃. After the reaction was completed, purification was performed by column chromatography to obtain BD103 as a yellowish green solid (4.6g,5.1mmol, 84% yield). The product was identified as the target product with a molecular weight of 908.5.
Synthetic example 12: synthesis of Compound BD25
First step of
Figure BDA0002495366720000253
Dissolving 4-olfactory-1-indanone (100g, 57mmol) in methanol (180mL), stirring in an ice water bath for half an hour, and adding NaBH in portions4(22.8g,600mol) until the reaction was complete, celite was filtered and the filtrate was concentrated.
The product was dissolved in dichloromethane and Et was added3SiH (67.4g,592mmol) was stirred in an ice-water bath for half an hour, gradually added dropwise TFA (103g,888mmol) and reacted until the starting material was completely reacted, and purified by column chromatography to obtain intermediate 37(44g,225mmol, 47% yield) as a colorless oil.
Second step of
Figure BDA0002495366720000254
Pd is added at room temperature under the protection of nitrogen2(dba)3(910mg,0.99mmol), BINAP (1.18g,1.99mmol), intermediate 37(4g,20.5mmol), [1,1' -Biphenyl]-3-amine (4.5g,24.6mmol) and tBuONa (3.9g,41mmol) were added to toluene (100mL) and the system was heated to 120 ℃ for 2 h. After the reaction was completed, purification was performed by column chromatography to obtain intermediate 38(6.2g,20.15mmol, yield 98%) as a colorless oily substance.
The third step
Figure BDA0002495366720000261
Under the protection of nitrogen at room temperature, 1, 6-dibromopyrene (2.5g,7mmol), intermediate 38(5.5g,16.2mmol), Pd (OAc)2(78mg,0.35mmol),tBu3PH+BF4 -(200mg,0.7mmol) and tBuONa (1.6g,16.2mmol), xylene (35mL) was added and the system was heated to 95 ℃. After the reaction was completed, purification was performed by column chromatography to obtain BD25(4g,5.1mmol, 69% yield) as a yellow-green solid. The product was identified as the target product with a molecular weight of 796.4.
Synthesis of comparative example 1: synthesis of comparative Compound A
The first step is as follows:
Figure BDA0002495366720000262
pd is added at room temperature under the protection of nitrogen2(dba3) (1g,1.1mmol), intermediate 3(5g,22.7mmol), 2-methylaniline (2.9g,27.2mmol), BINAP (1.4g,2.2mmol) and t-BuONa (4.3g,45.4mmol) were added to xylene (100mL) and the system was heated to 90 ℃ for reaction overnight. Purification by column chromatography after the reaction was complete gave intermediate 39(4g,17.4mmol, 76% yield) as a white solid.
Second step of
Figure BDA0002495366720000263
Under the protection of nitrogen at room temperature, 1, 6-dibromopyrene (2.5g,7.0mmol), intermediate 39(4g,16.2mmol), Pd (OAc)2(78mg,0.35mmol),tBu3PH+BF4 -(200mg,0.7mmol) and t-BuONa (1.6g,16.2mmol) were added to xylene (35mL) and the system was heated to 95 ℃ until the reaction was complete. And purified by column chromatography to give compound a as a yellow-green solid (3.4g,4.86mmol, 69%). The product was identified as the target product with a molecular weight of 700.4.
Synthesis of comparative example 2: synthesis of comparative Compound B
The first step is as follows:
Figure BDA0002495366720000264
pd is added at room temperature under the protection of nitrogen2(dba)3(910mg,0.99mmol), BINAP (1.18g,1.99mmol), intermediate 9(6g,19.9mmol), aniline (2.79g,30mmol) and tBuONa (3.8g,39.8mmol), toluene (100mL) was added and the system was heated to 120 ℃ for 3 h. After the reaction was completed, purification was performed by column chromatography to obtain intermediate 40(5.3g,16.9mmol, yield 85%) as a colorless oil.
The second step is that:
Figure BDA0002495366720000271
1, 6-di-olpyrene (2.38g, 6.6mmo1), intermediate 40(4.76g, 15.2mmo1), Pd (OAc) under the protection of nitrogen at room temperature2(74mg,0.33mmol),t-Bu3P·HBF4(191mg,0.66mmol) and t-BuONa (1.46g,15.2mmol) were added to xylene (30mL) and the system was heated to 95 ℃. After the reaction was completed, it was purified by column chromatography to obtain comparative compound B (4.68g,5.67mmol, 86%) as a yellowish green solid. The product was identified as the target product with a molecular weight of 824.4.
It will be appreciated by those skilled in the art that the above preparation method is only an illustrative example, and that those skilled in the art can modify it to obtain other structures of the compounds of the present invention.
Device example 1
First, a glass substrate, having an Indium Tin Oxide (ITO) anode 80nm thick, was cleaned and then treated with oxygen plasma and UV ozone. After treatment, the substrate was dried in a glove box to remove moisture. The substrate is then mounted on a substrate holder and loaded into a vacuum chamber. The organic layer specified below was in a vacuum of about 10 degrees-8In the case of torr, the evaporation was performed by thermal vacuum evaporation at a rate of 0.2 to 2 angstroms/second in turn on an ITO anode. Compound HI was used as Hole Injection Layer (HIL). The compound HT is used as a Hole Transport Layer (HTL). Compound EB was used as an Electron Blocking Layer (EBL). Then compound BD32 was doped in compound BH and co-evaporated to serve as the light emitting layer (EML). Compound HB was used as a Hole Blocking Layer (HBL). On the hole blocking layer, compound ET and 8-hydroxyquinoline-lithium (Liq) were co-evaporated as an Electron Transport Layer (ETL). Finally, 8-hydroxyquinoline-lithium (Liq) was evaporated to a thickness of 1nm as an electron injection layer, and 120nm of aluminum as a cathode. The device was then transferred back to the glove box and encapsulated with a glass lid and moisture absorber to complete the device.
Device example 2
Device example 2 was carried out in the same manner as in device example 1 except that the compound BD1141 was used in place of the compound BD32 in the light-emitting layer (EML).
Device example 3
Device example 3 was carried out in the same manner as in device example 1 except that the compound BD151 was used in place of the compound BD32 in the light-emitting layer (EML).
Device example 4
Device example 4 was carried out in the same manner as in device example 1 except that the compound BD1148 was used in place of the compound BD32 in the light-emitting layer (EML).
Device example 5
Device example 5 was carried out in the same manner as in device example 1 except that the compound BD250 was used in place of the compound BD32 in the light-emitting layer (EML).
Device example 6
Device example 6 was carried out in the same manner as in device example 1 except that the compound BD441 was used instead of the compound BD32 in the light-emitting layer (EML).
Device comparative example 1
Device comparative example 1 was conducted in the same manner as in device example 1 except that compound a was used in place of compound BD32 in the light-emitting layer (EML).
Device comparative example 2
Device comparative example 2 was conducted in the same manner as in device example 1 except that the compound B was used in place of the compound BD32 in the light emitting layer (EML).
The detailed structure and thickness of the device layer portions are shown in table 1. Wherein more than one layer of the materials used is obtained by doping different compounds in the stated weight ratios.
TABLE 1 device structures of device examples and comparative examples
Figure BDA0002495366720000281
The material structure used in the device is as follows:
Figure BDA0002495366720000291
Figure BDA0002495366720000301
IVL was measured for all the examples and comparative devices at different current densities and voltages, while the evaporation temperature was measured. At a constant current of 1000cd/m2Next, the External Quantum Efficiency (EQE), the maximum emission wavelength (. lamda.) was measuredmax) Full width at half maximum (FWHM) and CIE data.
TABLE 2 device data for example 1, example 2, comparative example 1 and comparative example 2
Device numbering CIE(x,y) λmax(nm) FWHM(nm) EQE(%)
Example 1 0.135,0.117 461 29.7 9.11
Example 2 0.133,0.129 463 30.5 9.02
Comparative example 1 0.136,0.127 461 31.7 8.43
Comparative example 2 0.133,0.133 463 30.5 8.65
Discussion:
device data for example 1, example 2, comparative example 1 and comparative example 2 are shown in table 2. Compared with comparative example 1, it can be seen that when one aryl group of the arylamine is biaryl, the EQE is improved by nearly 8.07% (9.11vs.8.43), the half-peak width is narrowed by 2nm (29.7nm vs.31.7nm), and the device performance is effectively improved.
In addition, the EQE of example 2 was improved by nearly 4.28% compared to comparative example 2, and the half-peak width and maximum emission wavelength were maintained. In example 2, it is seen that, when one aryl group of the aromatic amine is a biaryl group, the EQE can be improved and the blue emission performance can be effectively increased, as compared with comparative example 2.
Table 3 device data for example 3 and example 4
Device numbering CIE(x,y) λmax(nm) FWHM(nm) EQE(%)
Example 3 0.133,0.120 462 28.5 9.48
Example 4 0.135,0.118 461 29.7 9.12
Discussion:
device data for examples 3 and 4 are shown in table 3. In example 4, methyl is further introduced at the N-ortho position of the arylamine, compared with the N-ortho position of the arylamine in example 2 without substituent, the EQE is improved (9.12vs.9.02), the half-peak width is narrowed (29.7nm vs.30.5nm), and the maximum emission wavelength is also subjected to blue shift (461nm vs. 463nm). The result shows that on the basis that one aryl of the arylamine is biaryl, the blue luminescence property can be further improved by introducing alkyl substituent groups at the N-ortho position of the aryl.
The N-ortho position of the aromatic amine in example 3 further introduced neopentyl groups, and compared with the N-ortho position of the aromatic amine in example 1 introduced methyl groups, the addition of ortho substituents and the gradual increase of EQE (9.48vs.9.11) with the increase of molecular volume of ortho substituents, and the narrowing of half-peak width (28.5nm vs.29.7nm) were followed. Both EQE and half-peak width were improved compared to comparative example 1. The result shows that on the basis that the arylamine has a double structure of a benzo five-membered ring and a biaryl substituent, the blue luminescence property can be further improved by introducing the substituent at the N-ortho position, and the influence is increased along with the increase of the molecular volume of the N-ortho position substituent.
Table 4 device data for example 5 and example 6
Device numbering CIE(x,y) λmax(nm) FWHM(nm) EQE(%)
Example 5 0.139,0.089 456 31.3 8.99
Example 6 0.140,0.089 455 29.4 8.71
Discussion:
device data for examples 5 and 6 are shown in table 3. Examples 5 and 6 introduce a fluorine substitution in the N-meta position of the arylamine aryl group and blue shift the maximum emission wavelengths by 7nm (456nm vs.463nm) and 6nm (455nm vs.461nm), respectively, compared to examples 2 and 1 without the fluorine substitution. The result shows that the introduction of fluorine substitution can enable the maximum emission wavelength to be blue-shifted on the basis of the double structure that the arylamine has the benzo five-membered ring and the biaryl substituent, so as to achieve the deep blue luminescence.
TABLE 5 deposition temperature of device examples inventive compounds
Compound (I) BD31 BD151 BD441 BD250
Deposition temperature/. degree.C 228.5 230.0 236.0 209.0
The vapor deposition temperature data for the compounds of the present invention in the device examples are shown in Table 5, wherein the vapor deposition temperature is about 10 degrees of vacuum-8The torr material was vapor deposited at a rate of 0.04 angstroms/second. The compound disclosed by the invention improves the performance of the device, and meanwhile, the evaporation temperature of the material is mild, thereby being beneficial to the thermal stability required by the industry for the material.
In conclusion, in the aromatic amine substituted pyrene compound, one substituent of the aromatic amine is a substituted or unsubstituted ortho (hetero) aryl and penta (hetero) cyclic hydrocarbon structure, and the other is a substituted or unsubstituted bi (hetero) aryl, especially a substituted or unsubstituted biaryl not more than two aryl (phenyl) groups, and the novel compound obtained by combining the structure can realize a blue emission wavelength, a high EQE and a narrow half-peak width when being applied to an organic electroluminescent device, so that the comprehensive performance of the device is improved. Meanwhile, fluorine substitution or N-ortho substitution is introduced into the other (hetero) aryl group, so that the blue luminescence property can be further improved. The compound disclosed by the invention improves the performance of the device, and meanwhile, the evaporation temperature of the material is mild, thereby being beneficial to the thermal stability required by the industry for the material.
It should be understood that the various embodiments described herein are illustrative only and are not intended to limit the scope of the invention. Thus, the invention as claimed may include variations from the specific embodiments and preferred embodiments described herein, as will be apparent to those skilled in the art. Many of the materials and structures described herein may be substituted with other materials and structures without departing from the spirit of the present invention. It should be understood that various theories as to why the invention works are not intended to be limiting.

Claims (17)

1. A compound having the formula 1:
Figure FDA0002495366710000011
wherein, in the formula 1,
substituent R1-R10At least one of which has the structure of formula 2:
Figure FDA0002495366710000012
and the substituent R1-R10The remaining of (a) are, identically or differently on each occurrence, selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amino, acyl, carbonyl, carboxylic acid group, ester group, cyano, isocyano, mercapto, sulfinyl, sulfonyl, phosphino, and combinations thereof, having from 0 to 20 carbon atoms;
wherein, in the formula 2,
l is selected from a single bond, a substituted or unsubstituted arylene group having 6 to 60 carbon atoms, a substituted or unsubstituted heteroarylene group having 3 to 60 carbon atoms, or a combination thereof;
X1-X3selected from CR, identically or differently at each occurrencexOr N;
Y1and Y5Selected from CR, identically or differently at each occurrencey1Or N;
Y2-Y4selected from CR, identically or differently at each occurrencey2、CRy3Or N, and Y2-Y4At least one of which is CRy2
Z is selected, identically or differently on each occurrence, from C (R)z)2,NRzO, S or Se;
Rx、Ry3and RzEach occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amino, acyl, carbonyl, carboxylic acid group, ester group, cyano, isocyano, mercapto, sulfinyl, sulfonyl, phosphino, and combinations thereof, having from 0 to 20 carbon atoms;
Ry1each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, and combinations thereof;
Ry2each occurrence, identically or differently, is selected from a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, or a combination thereof;
adjacent substituents Rx、Ry1、Ry3Can optionally be linked to form a ring;
substituent RzCan optionally be linked to form a ring;
and represents the position of the substituent with the structure of the formula 2 connected with the formula 1.
2. The compound of claim 1, wherein substituent R1To R10At least two of which have the structure of formula 2; preferably, R1To R10Two of which have the structure of formula 2.
3. The compound of claim 2, wherein substituent R1And R6Has the structure of formula 2.
4. A compound according to claim 3, wherein the substituent R2,R4-R5,R7And R9-R10Is a hydrogen atom, a substituent R3And R8Each occurrence, identically or differently, is selected from hydrogen, deuterium, a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, or a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms.
5. The compound of any one of claims 1-4, wherein L, identically or differently at each occurrence, is selected from a single bond, a substituted or unsubstituted arylene having 6 to 30 carbon atoms, a substituted or unsubstituted heteroarylene having 3 to 30 carbon atoms, or a combination thereof;
preferably, wherein L is a single bond.
6. The compound of any one of claims 1-5, wherein X1To X3Selected from CR, identically or differently at each occurrencex,Y1And Y5Selected from CR, identically or differently at each occurrencey1,Y2-Y4Selected from CR, identically or differently at each occurrencey2And CRy3And Y is2-Y4At least one of which is CRy2
7. The compound of any one of claims 1-6, wherein RxEach occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, and combinations thereof;
preferably, said R isxEach occurrence, identically or differently, is selected from hydrogen, deuterium, fluoro, methyl, ethyl, isopropyl, cyclopentyl, cyclohexyl, phenyl, methylphenyl, isopropylphenyl, or a combination thereof.
8. The compound of any one of claims 1-7, wherein Y is2-Y4Selected from CR, identically or differently at each occurrencey2And CRy3And Y is2-Y4At least one of which is CRy2
The R isy3Each occurrence identically or differently selected from the group consisting of hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 6 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 6 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 6 carbon atoms, substituted or unsubstituted aryl groups having 6 to 12 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 12 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 6 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 12 carbon atoms, and combinations thereof;
preferably, wherein Ry3Each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, fluoro, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, n-butyl, isobutyl, tert-butyl, cyclopentyl, cyclohexyl, phenyl, trimethylsilyl, and combinations thereof;
the R isy2Each occurrence, identically or differently, is selected from a substituted or unsubstituted aryl group having 6 to 24 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 24 carbon atoms, or a combination thereof;
preferably, said R isy2Each occurrence, the same or different, is selected from phenyl, 2-methylphenyl, 2-ethylphenyl, 2-isopropylphenyl, 2-tert-butylphenyl, biphenyl, terphenyl, quaterphenyl, triphenylene, tetraphenylene, 2-naphthyl, phenanthrene, anthracene, indene, fluorene, indole, carbazole, benzofuran, dibenzofuran, benzothiole, dibenzothiaole, benzothiophene, dibenzothiophene, dibenzoselenophene, or a combination thereof.
9. The compound of any one of claims 1-8, wherein Y is2-Y4Selected from CR, identically or differently at each occurrencey2And CRy3And Y is2-Y4One of them is CRy2The balance being CRy3
The R isy3Each occurrence identically or differently selected from the group consisting of hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 6 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 6 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 6 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 6 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 12 carbon atoms, and combinations thereof;
preferably, wherein Ry3Each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, fluoro, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, n-butyl, isobutyl, tert-butyl, cyclopentyl, cyclohexyl, phenyl, trimethylsilyl, and combinations thereof;
the R isy2Each occurrence, identically or differently, is selected from a substituted or unsubstituted aryl group having 6 to 24 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 24 carbon atoms, or a combination thereof;
preferably, said R isy2Each occurrence being identical or different and is selected from the group consisting of phenyl, 2-methylphenyl, 2-ethylphenyl, 2-isopropylphenyl, 2-tert-butylphenyl, biphenyl, terphenyl, quaterphenyl, triphenylene, tetraphenylene, 2-naphthyl, phenanthrene, anthracene, indene, fluorene, indole, carbazole, benzofuran, dibenzofuran, benzothiole, bisbiphenylBenzothiole, benzothiophene, dibenzothiophene, dibenzoselenophene, deuterated 2-methylphenyl, deuterated 2-ethylphenyl, deuterated 2-isopropylphenyl, deuterated 2-tert-butylphenyl, or combinations thereof.
10. The compound of any one of claims 1-9, wherein Y is1And Y5Selected from CR, identically or differently at each occurrencey1And said R isy1Each occurrence, identically or differently, is selected from hydrogen, deuterium, halogen, substituted or unsubstituted alkyl having 1 to 6 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 6 ring carbon atoms, or combinations thereof;
preferably, said R isy1Each occurrence, which may be the same or different, is selected from the group consisting of hydrogen, deuterium, fluorine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, n-butyl, isobutyl, tert-butyl, cyclopentyl, neopentyl, cyclohexyl, deuterated methyl, deuterated ethyl, deuterated n-propyl, deuterated isopropyl, deuterated cyclopropyl, deuterated n-butyl, deuterated isobutyl, deuterated tert-butyl, deuterated cyclopentyl, deuterated neopentyl, deuterated cyclohexyl, or a combination thereof.
11. The compound of any one of claims 1-10, wherein Z is C (R)z)2And said R iszEach occurrence identically or differently selected from hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, or combinations thereof;
preferably, RzEach occurrence, identically or differently, is selected from hydrogen, halogen, deuterium, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, n-butyl, isobutyl, tert-butyl, cyclopentyl, cyclohexyl, or a combination thereof;
substituent RzCan optionally be linked to form a ring.
12. The compound of any one of claims 1-11, wherein Rx、Ry1And Ry3At least one of which is fluorine.
13. The compound of claim 1, wherein the compound is selected from the group consisting of:
Figure FDA0002495366710000031
Figure FDA0002495366710000041
Figure FDA0002495366710000051
Figure FDA0002495366710000061
Figure FDA0002495366710000071
Figure FDA0002495366710000081
Figure FDA0002495366710000091
Figure FDA0002495366710000101
Figure FDA0002495366710000111
Figure FDA0002495366710000121
Figure FDA0002495366710000131
Figure FDA0002495366710000141
Figure FDA0002495366710000151
Figure FDA0002495366710000161
Figure FDA0002495366710000171
Figure FDA0002495366710000181
Figure FDA0002495366710000191
Figure FDA0002495366710000201
Figure FDA0002495366710000211
Figure FDA0002495366710000221
Figure FDA0002495366710000231
Figure FDA0002495366710000241
Figure FDA0002495366710000251
Figure FDA0002495366710000261
Figure FDA0002495366710000271
Figure FDA0002495366710000281
Figure FDA0002495366710000291
Figure FDA0002495366710000301
Figure FDA0002495366710000311
Figure FDA0002495366710000321
Figure FDA0002495366710000331
Figure FDA0002495366710000341
Figure FDA0002495366710000351
Figure FDA0002495366710000361
Figure FDA0002495366710000371
Figure FDA0002495366710000381
Figure FDA0002495366710000391
Figure FDA0002495366710000401
Figure FDA0002495366710000411
Figure FDA0002495366710000421
Figure FDA0002495366710000431
Figure FDA0002495366710000441
Figure FDA0002495366710000451
Figure FDA0002495366710000461
Figure FDA0002495366710000471
Figure FDA0002495366710000481
Figure FDA0002495366710000491
Figure FDA0002495366710000501
Figure FDA0002495366710000511
Figure FDA0002495366710000521
Figure FDA0002495366710000531
Figure FDA0002495366710000541
Figure FDA0002495366710000551
Figure FDA0002495366710000561
Figure FDA0002495366710000571
Figure FDA0002495366710000581
Figure FDA0002495366710000591
Figure FDA0002495366710000601
Figure FDA0002495366710000611
Figure FDA0002495366710000621
Figure FDA0002495366710000631
Figure FDA0002495366710000641
Figure FDA0002495366710000651
Figure FDA0002495366710000661
Figure FDA0002495366710000671
Figure FDA0002495366710000681
Figure FDA0002495366710000691
Figure FDA0002495366710000701
Figure FDA0002495366710000711
Figure FDA0002495366710000721
Figure FDA0002495366710000731
Figure FDA0002495366710000741
Figure FDA0002495366710000751
Figure FDA0002495366710000761
Figure FDA0002495366710000771
Figure FDA0002495366710000781
Figure FDA0002495366710000791
Figure FDA0002495366710000801
Figure FDA0002495366710000811
Figure FDA0002495366710000821
Figure FDA0002495366710000831
Figure FDA0002495366710000841
Figure FDA0002495366710000851
Figure FDA0002495366710000861
Figure FDA0002495366710000871
Figure FDA0002495366710000881
Figure FDA0002495366710000891
Figure FDA0002495366710000901
Figure FDA0002495366710000911
Figure FDA0002495366710000921
Figure FDA0002495366710000931
Figure FDA0002495366710000941
Figure FDA0002495366710000951
Figure FDA0002495366710000961
Figure FDA0002495366710000971
Figure FDA0002495366710000981
Figure FDA0002495366710000991
Figure FDA0002495366710001001
Figure FDA0002495366710001011
Figure FDA0002495366710001021
Figure FDA0002495366710001031
Figure FDA0002495366710001041
Figure FDA0002495366710001051
Figure FDA0002495366710001061
Figure FDA0002495366710001071
Figure FDA0002495366710001081
Figure FDA0002495366710001091
Figure FDA0002495366710001101
Figure FDA0002495366710001111
Figure FDA0002495366710001121
Figure FDA0002495366710001131
Figure FDA0002495366710001141
Figure FDA0002495366710001151
Figure FDA0002495366710001161
Figure FDA0002495366710001171
Figure FDA0002495366710001181
Figure FDA0002495366710001191
Figure FDA0002495366710001201
Figure FDA0002495366710001211
Figure FDA0002495366710001221
Figure FDA0002495366710001231
Figure FDA0002495366710001241
Figure FDA0002495366710001251
Figure FDA0002495366710001261
Figure FDA0002495366710001271
Figure FDA0002495366710001281
Figure FDA0002495366710001291
Figure FDA0002495366710001301
14. an electroluminescent device comprising:
an anode, a cathode, a anode and a cathode,
a cathode electrode, which is provided with a cathode,
and an organic layer disposed between the anode and the cathode, the organic layer comprising a compound having formula 1:
Figure FDA0002495366710001302
wherein, in the formula 1,
substituent R1-R10At least one of which has the structure of formula 2:
Figure FDA0002495366710001303
and the substituent R1-R10The remaining of (a) are, identically or differently on each occurrence, selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl having 2 to 20 carbon atoms, substituted or unsubstituted aryl having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl having 3 to 20 carbon atoms, substituted or unsubstituted alkyl having 6 to 20 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 20 carbon atoms, or substituted or unsubstituted cycloalkyl having 3 to 20 carbon atomsAn arylsilyl group of carbon atoms, a substituted or unsubstituted amino group having 0 to 20 carbon atoms, an acyl group, a carbonyl group, a carboxylic acid group, an ester group, a cyano group, an isocyano group, a mercapto group, a sulfinyl group, a sulfonyl group, a phosphino group, and combinations thereof;
wherein, in the formula 2,
l is selected from a single bond, a substituted or unsubstituted arylene group having 6 to 60 carbon atoms, a substituted or unsubstituted heteroarylene group having 3 to 60 carbon atoms, or a combination thereof;
X1-X3is CRxOr N;
Y1and Y5Selected from CR, identically or differently at each occurrencey1Or N;
Y2-Y4selected from CR, identically or differently at each occurrencey2、CRy3Or N, and Y2-Y4At least one of which is CRy2
Z is selected, identically or differently on each occurrence, from C (R)z)2,NRzO, S or Se;
Rx、Ry3and RzEach occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amino, acyl, carbonyl, carboxylic acid group, ester group, cyano, isocyano, mercapto, sulfinyl, sulfonyl, phosphino, and combinations thereof, having from 0 to 20 carbon atoms;
Ry1identical or different at each occurrenceIs selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, and combinations thereof;
Ry2each occurrence, identically or differently, is selected from a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, or a combination thereof;
adjacent substituents Rx、Ry1、Ry3Can optionally be linked to form a ring;
substituent RzCan optionally be linked to form a ring;
and represents the position of the substituent with the structure of the formula 2 connected with the formula 1.
15. The organic electroluminescent device as claimed in claim 14, wherein the organic layer comprises a light emitting layer, wherein the light emitting layer comprises a compound having formula 1.
16. The organic electroluminescent device of claim 15, wherein the light emitting layer further comprises a compound having formula 3:
Figure FDA0002495366710001311
wherein, in the formula 3,
Rg1to Rg8Each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl having 2 to 20 carbon atoms, substituted or unsubstituted aryl having 6 to 30 carbon atoms, substituted or unsubstituted aryl having 3 to 30 carbon atomsSubstituted or unsubstituted alkylsilyl group of 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl group of 6 to 20 carbon atoms, substituted or unsubstituted amino group of 0 to 20 carbon atoms, acyl group, carbonyl group, carboxylic acid group, ester group, cyano group, isocyano group, mercapto group, sulfinyl group, sulfonyl group, phosphino group, and combinations thereof;
Rg9and Rg10Each occurrence, identically or differently, is selected from substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, or substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms.
17. A compound formulation comprising a compound of any one of claims 1-13.
CN202010418297.9A 2020-05-18 2020-05-18 Aromatic amine derivative organic electroluminescent material and device thereof Pending CN113683517A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010418297.9A CN113683517A (en) 2020-05-18 2020-05-18 Aromatic amine derivative organic electroluminescent material and device thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010418297.9A CN113683517A (en) 2020-05-18 2020-05-18 Aromatic amine derivative organic electroluminescent material and device thereof

Publications (1)

Publication Number Publication Date
CN113683517A true CN113683517A (en) 2021-11-23

Family

ID=78575430

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010418297.9A Pending CN113683517A (en) 2020-05-18 2020-05-18 Aromatic amine derivative organic electroluminescent material and device thereof

Country Status (1)

Country Link
CN (1) CN113683517A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110156016A1 (en) * 2008-07-28 2011-06-30 Masahiro Kawamura Organic light-emitting medium and organic el element
JP2013118288A (en) * 2011-12-02 2013-06-13 Toyo Ink Sc Holdings Co Ltd Material for organic electroluminescent device and application of the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110156016A1 (en) * 2008-07-28 2011-06-30 Masahiro Kawamura Organic light-emitting medium and organic el element
JP2013118288A (en) * 2011-12-02 2013-06-13 Toyo Ink Sc Holdings Co Ltd Material for organic electroluminescent device and application of the same

Similar Documents

Publication Publication Date Title
CN109912619B (en) Organic electroluminescent materials and devices
CN109422770B (en) Boron-containing heterocyclic compounds for OLEDs, organic light emitting devices, and compound formulations comprising the same
CN109422666B (en) Hole injection layer and charge generation layer containing a truxene-based compound
CN111518139A (en) Organic luminescent material containing cyano-substituted ligand
CN110922429A (en) Organic luminescent material containing novel auxiliary ligand
CN109651065B (en) Tetraortho-phenylene anthracene compounds
CN109694368B (en) Indolocarbazole tetraphthalene compounds
CN111675697B (en) Organic electroluminescent material and device thereof
CN111196822A (en) Compound containing silicon fluorenyl and fluorenyl structures and electroluminescent device containing compound
CN112876489B (en) Organic electroluminescent material and device thereof
CN109836435B (en) Triarylamine compounds containing thiophene
CN112778283B (en) Organic electroluminescent material and device thereof
CN109796499B (en) Metal complexes of azabenzothiazoles containing nitrogen
CN114907412A (en) Organic electroluminescent material and device thereof
CN111620853A (en) Organic electroluminescent material and device thereof
CN111018921A (en) Metal complex and electroluminescent device containing same
CN113527316A (en) Electroluminescent material and device
CN111333611B (en) Organic electroluminescent material and device thereof
CN113527315A (en) Electroluminescent material and device
CN109575085B (en) Organic luminescent material containing tetra-ortho-phenylene ligand
CN112430190B (en) Aromatic amine derivative and organic electroluminescent device comprising same
CN113493482A (en) Organic light-emitting materials containing cyano-substituted ancillary ligands
CN113527317A (en) Electroluminescent material and device
CN112390780A (en) Electron transport material containing azaspirobifluorene
CN111039928B (en) Organic electroluminescent material containing spiroalkene structure and device

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination